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Abstract
Microbial biosynthesis is a sustainable and high-specificity means of producing various
bioproducts, including pharmaceuticals, specialty and commodity chemicals, and biofuels.
Due to the complexity of microorganisms, it is frequently difficult to rationally engineer
them, which necessitates iterative rounds of design, construction, and testing to generate
high-producing strains. Furthermore, it can be difficult to optimize multiple functions in
the same microorganism. Microbial consortia are abundant in natural environments and
can offer unique properties that are not attainable by monocultures. Design principles have
begun to be developed for synthetic consortia and further maturation of this field will lead to
many exciting new opportunities in microbial bioprocessing. In this dissertation, we describe
two cases of utilizing microbial consortia, one as a tool for screening microbial libraries, and
the other as a division-of-labor approach for accomplishing the complex task of lignocellulosic
biofuel production.
First, we demonstrate that a cross-feeding metabolic circuit can convert production
phenotypes into growth phenotypes, which are highly screenable. This technology, which
we term Syntrophic Co-culture Amplification of Production phenotype (SnoCAP), has two
valuable properties that are not present in monocultures: (1) it has a highly tunable dy-
namic range, and (2) it amplifies small differences between strains. We implemented three
different compartmentalization schemes of increasing throughput capability: microplates
(102-104 strains evaluated/experiment), agar plates (104-105 strains evaluated/experiment),
and microdroplets (105-107 strains evaluated/experiment). We demonstrated SnoCAP’s
ability to differentiate between Escherichia coli strains of differing production levels for
2-ketoisovalerate (2-KIV), a precursor of the drop-in biofuel isobutanol, and L-tryptophan, a
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precursor for several pharmaceutically active compounds. We then used SnoCAP to screen
a chemically mutagenized library and identify an efficient isobutanol production strain that
reaches a 5-fold higher titer than the parent strain. We expect SnoCAP can be applied to the
screening of a wide variety of target molecules for which high-throughput screening assays
do not currently exist.
Second, we examine a previously developed co-culture of the cellulolytic fungus Tricho-
derma reesei and isobutanol-producing E. coli for consolidated bioprocessing of lignocellu-
losic biomass to biofuel. This approach provides division-of-labor, distributing the metabolic
burden and allowing optimization of hydrolysis and fermentation separately. We work toward
improving this co-culture by engineering the E. coli strains for improved performance under
co-culture conditions. Due to observed issues with plasmid loss, we developed strains with
the isobutanol pathway integrated into the genome. We used the chemically inducible chro-
mosomal evolution (CIChE) method to achieve high copy number of the genes responsible
for the conversion of 2-KIV to isobutanol. We then explored the use of position-dependent
expression variation, in conjunction with SnoCAP screening, to optimize expression of an-
other gene crucial for the synthesis of 2-KIV. Additionally, we developed a framework for
adaptive evolution of the T. reesei/E. coli co-culture. We expect that this method may
be used on a strain with the isobutanol pathway integrated into the genome to select for
variants that are well-suited to production under co-culture conditions.
In summary, this work contributes to the development of synthetic microbial consortia
for biochemical production. We have demonstrated that the properties of cross-feeding
metabolic circuits can be exploited as a useful high-throughput screening tool. We have
also explored a synthetic fungal-bacterial consortium that divides the labor of lignocellulosic
biomass conversion between two specialist strains and developed new approaches to optimize
the fermentation specialist for the unusual conditions it encounters in the co-culture.
xv
Chapter 1: Background and motivation
1.1 Strategies for high-throughput metabolite detection
1.1.1 A brief overview of industrial microbiology and the need for phenotype
screening techniques
Microbial biosynthesis offers an attractive approach to producing many chemicals.
Compared to chemical synthesis, bioproduction generally does not require harsh chemicals or
process conditions, making it safer and more environmentally friendly. Microbial processes
also have a superior capacity for stereospecificity and regiospecificity compared to synthetic
chemistry. Fermentation of food products has been practiced since prehistoric times. Sci-
entific understanding of these processes began to emerge in the 1850s with Louis Pasteur’s
studies of yeast fermentation. Subsequent study of yeast led to the discovery of enzymes
and multi-step pathways. New chemical demands caused by World War I led to efforts in
industrial strain engineering. In these early days of industrial microbiology, strain develop-
ment generally proceeded by starting with strains that could produce small amounts of a
target molecule and subjecting them to iterative rounds random mutagenesis and screening
or selection for higher-producing strains. This approach led to notable successes, includ-
ing the production of penicillin by Penicillium chrysogenum. Rounds of mutagenesis and
screening increased production from titers of less than 1 g/L to more than 20 g/L [1]. While
effective, a drawback to such brute force screening approaches is their labor-intensive nature.
An alternative is to use selections that enrich for the target population. In the 1950s and
60s, successes in constructing amino acid overproducers began to be reported by selecting
1
for Corynebacterium strains that were resistant to toxic amino acid analogs [2].
With the advent of cloning techniques, recombinant DNA technology and improved
understanding of biochemistry, new strategies of rational design became possible, leading to
the emergence of the field of metabolic engineering in the 1990s. Today, we use metabolic
engineering to produce an ever-expanding collection of useful, value-added chemicals, in-
cluding pharmaceuticals, specialty and commodity chemicals, and biofuels. The three major
components of metabolic engineering are pathway design, construction, and optimization.
Optimization of titer, rate, and yield is essential since the ultimate goal is an industrially vi-
able strain [3]. If the product is not continuously removed during production then the strain’s
tolerance to the product may also require improvement since the cells need to be able to
survive and continue to function at high concentrations of the produced compound. Even
molecules that are essential at low concentrations (e.g., amino acids) can become inhibitory
at high concentrations.
Combinatorial methods have proved effective for achieving the optimization step. Strate-
gies for combinatorial genetic diversity generation are reviewed in [4]. Some examples include
genome shuﬄing, gene knockout libraries, overexpression libraries, and global transcription
machinery engineering. For fine-tuning gene expression, techniques such as multiplex au-
tomated genome engineering (MAGE) [5], customized optimization of metabolic pathways
by combinatorial transcriptional engineering (COMPACTER) [6], and tunable intergenic
regions (TIGRs) [7] enable construction of combinations of different expression levels of a
pathway’s genes. Libraries of great diversity can be created using these combinatorial meth-
ods and it is often important to be able to screen as many members as possible.
An illustrative example of successful metabolic engineering is the development of mi-
crobial production of the antimalarial drug precursor artemisinic acid by the Keasling group
at UC Berkeley ( [8] provides a summary of the work). While introduction of the pathway
initially led to low titers and cell viability issues, intensive optimization efforts produced an
Saccharomyces cerevisiae strain capable of producing 25 g/L artemisinic acid. Production
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was further optimized by Amyris and industrial-scale production of this product is now un-
derway by Sanofi. During one stage of the work, the yeast mevalonate pathway was expressed
in Escherichia coli. Low titers were assumed to be due to a pathway imbalance leading to
the buildup of an inhibitory intermediate [9]. The TIGR strategy, which generates combi-
nations of post-transcriptional control elements, was developed and utilized to modulate the
expression levels of three pathway genes combinatorially. It was found that a variant with re-
duced expression of two of the enzymes achieved seven-fold higher mevalonate production [7].
Further analysis of the strains revealed that the intermediate 3-hydroxy-3-methyl-glutaryl-
coenzyme A (HMG-CoA) had been the inhibitory compound. Subsequently the gene for
HMG-CoA reductase was overexpressed, leading to increased titers. Thus the combinatorial
method led to insights that could not have been predicted purely by the rational design
methods available.
In addition to pharmaceuticals, biofuels are another area of interest for metabolic
engineering efforts. In 2008, the Liao group at UCLA reported production of various higher
alcohols by E. coli through their amino acid biosynthesis pathways by expression of an alpha-
ketoisovalerate decarboxylase (Kdc) and an alcohol dehydrogenase (Adh) and overexpressing
amino acid biosynthesis genes (Fig. 1.1A, [10]). Isobutanol was produced at high yield and
titer, making it a promising biofuel candidate. To optimize isobutanol production, two
parallel approaches were taken. One was a rationally guided approach to delete competing
pathways (Fig. 1.1B, [10]). The other was an evolutionary approach, involving chemical
mutagenesis followed by growth on a toxic analog of leucine/valine to select for high flux
through this pathway, followed by overexpression of the pathway genes, and screening for
isobutanol production [11]. Both strategies proved highly effective. Further work has been
done to optimize the process, including in situ isobutanol removal that enabled production of
>50 g/L isobutanol in 72 h [12] and resolution of a cofactor imbalance that led to anaerobic
isobutanol production at 100% theoretical yield [13]. Industrial-scale microbial production
of isobutanol has begun by Gevo and is planned by Butamax.
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Figure 1.1: Non-fermentative alcohol production in E. coli. (A) Various higher alcohols that can
be produced in E. coli. Reproduced from [10]. (B) Strategy for increasing isobutanol production
in strain JCL260 by deletion of competing pathways [10]. Reproduced from: http://www.arpa-
e.energy.gov/
Once a strain of high production-level is attained, either by random mutagenesis or
by more rational methods, it is often of interest to identify the specific mutations that have
caused the desired phenotype. Separating the causative mutations from silent mutations can
improve understanding and aid future strain engineering efforts. Inverse metabolic engineer-
ing (IME), introduced by Bailey et al. in 1996 [14], is a widely used approach to isolate the
causative mutations. Here genome fragments can be cloned into plasmids or mutations can
be reintroduced into the genome individually. Mutations can then be tested for their indi-
vidual contributions. An IME step also requires screening libraries and it is most effective if
the entire library can be assessed. As the complexity of the manipulated system increases, so
does the genotype/phenotype space that one wishes to explore (Fig. 1.2A). Construction of
vast libraries to explore network, and genome space is possible, but they are only practically
useful if they can be screened efficiently.
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Due to the diversity of small molecule properties, methods for their detection are much
less generalizable than genetic diversity generation and frequently are the bottleneck in
strain engineering efforts. Molecules with colorimetric or fluorescent properties can enable
visual evaluation or fluorescence-activated cell sorting (FACS), thus reaching significantly
higher throughputs (Fig. 1.2B). For example, the production levels of antioxidants ly-
copene and β-carotene can be assessed by the shade of a bacterial colony on an agar plate.
Molecules that can produce optical readouts can also be screened using droplet microflu-
idics platforms, which enables high-throughput screening for extracellular production levels.
Most target molecules, however, are inconspicuous and the standard way to assess them is
chromatography- or mass-spectrometry-based assays, which at best evaluate only hundreds
to thousands of variants per day. High-throughput mass spectrometry with microdroplets
has been proposed as a generalizable solution but has yet to be fully realized for strain
engineering purposes.
Figure 1.2: Strain engineering and screening. (A) Genotype/phenotype space explored by gene,
network and genome engineering. Reproduced from [15]. (B) Throughputs of various metabolite
detection schemes. Reproduced from [16].
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1.1.2 Biosensors for high-throughput screening
Biosensors that can transduce inconspicuous molecule concentrations into conspicuous
outputs such as fluorescence or growth advantages are an appealing approach to increasing
screening throughputs, leading to significant research efforts in this area. Biosensor strategies
are reviewed in [4, 16, 17]. Biosensors are often developed in the context of environmental
contamination detection but most of these approaches are theoretically adaptable to strain
engineering, although they may require modification of the assay dynamic range.
One approach is to convert the target molecule into a fluorescent compound via enzy-
matic and/or chemical reactions or to use chromogenic or fluorescent dyes to make the target
molecule easily detectable. For example, Santos & Stephanopoulos developed a colorimetric
assay for tyrosine production by E. coli by expressing a tyrosinase that converts tyrosine to
the black pigment melanin [18].
Other approaches utilize biosensing machinery that responds to the presence of the
target molecule in a dose-dependent manner. This machinery may consist of proteins, nucleic
acids, or whole cells and may be located within the production strain itself, or outside of the
cell. Protein strategies include transcription factors (either native or engineered), G-protein-
coupled receptors, and fluorescent proteins with added ligand binding properties. Binding
of the target molecule triggers the protein to change conformation and produce a response,
either downstream or in the protein itself, in the case of fluorescent proteins. For example,
a transcription factor that is responsive to a target molecule can be configured such that
it regulates a promoter controlling a fluorescent protein’s expression. These protein-based
methods are highly useful but generally require a dedicated protein engineering effort for
each target molecule in order to achieve specificity and desirable dynamic range. They also
require an existing ligand-binding domain that already has some binding capability for the
target molecule, or at least a similarly structured molecule, from which to begin directed
evolution and/or computational design efforts.
Nucleic acid strategies have also been explored. Properties of nucleic acids are much
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easier to predict than those of proteins, and there has been much work into small molecule
aptamer design and directed evolution [19]. The relative ease of producing nucleic acids
with desirable binding properties makes them promising as generalizable biosensor strate-
gies. Riboswitches have been designed that produce downstream transcriptional responses
upon binding the molecule of interest and have been used as screens and selections in enzyme
directed evolution endeavors. RNA Spinach aptamers is another theoretically generalizable
strategy, in which the ligand-binding causes the aptamer to bind a dye and produce a fluo-
rescent output [20].
For the whole-cell approach, whole-cell auxotrophic biosensors are valuable tools for
accurately determining concentrations of metabolites in biological samples [21–27]; however,
they have not been widely employed for high-throughput strain screening endeavors. This
may be due to their typically small dynamic ranges, at very low concentrations of the focal
molecule (Fig. 1.3). A notable exception is an engineered mevalonate auxotroph that
was used for screening libraries for mevalonate production [28]. In this work, the producer
strain’s supernatant was diluted so that it fell into the dynamic range of the biosensor.
In the work presented in this dissertation, we make use of cross-feeding co-cultures
of microorganisms as a biosensing tool. Syntrophic co-cultures, consisting of auxotrophic
strains that cross-feed their required metabolites, enabling co-growth, are prevalent in nature
[29,30] and have been used historically by microbiologists as a tool to interrogate biochemical
pathways [31,32] and for assessment of whether a specific metabolite is produced by a strain
of interest [33]. Wintermute & Silver [34] and Mee et al. [35] have characterized co-growth
of a variety of synthetic combinations of auxotrophic E. coli strains. While the strains have
not been engineered to overproduce the amino acids that must be cross-fed, many of the
pairs can support co-growth (Fig. 1.4).
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Figure 1.3: Characterization of various amino acid auxotrophic strains. Reproduced from [25].
Figure 1.4: Growth of various combinations of auxotrophic strains. Reproduced from [34].
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1.2 Approaches for consolidated bioprocessing (CBP) of lignocel-
lulosic biomass
1.2.1 Motivation for CBP
Microbial processing of lignocellulosic material, an abundant and under-utilized carbon
source, into liquid fuels is a promising alternative to petroleum-based fuels, but production
costs using current technologies remain prohibitively high. Furthermore, the variable na-
ture of biomass across space and time means that processes need to be optimized for region
and season [36]. Cellulosic biofuel processes typically involve the following steps: (i) thermo-
chemical pretreatment to break down the biomass into its three major components (cellulose,
hemicellulose and lignin), (ii) enzymatic saccharification of cellulose and hemicellulose to hex-
ose and pentose sugars, (iii) microbial fermentation of soluble sugars to generate fuel, and (iv)
downstream processing to separate and concentrate the fuel [37]. Consolidated bioprocess-
ing (CBP), in which enzyme production, enzymatic hydrolysis, and microbial fermentation
occur in a single bioreactor (Fig. 1.5A), is believed to be the configuration of lowest cost,
provided a suitable microbe or combination of microbes can be developed (Fig. 1.5B) [38,39].
Figure 1.5: Cost savings of process consolidation. (A) Summary of process integration schemes
for cellulosic biofuel generation. Each box represents a bioreactor (not to scale). SHF, separate
hydrolysis and fermentation; SSF, simultaneous saccharification and fermentation; SSCF, simulta-
neous saccharification and co-fermentation; CBP, consolidated bioprocessing. Adapted from [36].
(B) Estimated cost reduction for various technological advances. Values represent the average of
two scenarios: 2,205 and 5,000 dry tons feedstock/day. Adapted from [40].
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The required traits for such a microbe are cellulase expression and secretion, biofuel
production, solvent tolerance, lignin tolerance, and elimination of carbon catabolite repres-
sion that inhibits metabolism of other sugars in the presence of glucose [36]. Much effort
toward CBP has been directed toward integrating all functionalities into a single organism,
either starting from a cellulolytic organism and engineering for high fuel yield and toler-
ance or starting with a productive fermentation strain and adding cellulolytic capabilities.
However, neither strategy has yet to result in an organism with sufficiently high yields and
productivities for commercial viability [39]. An alternative approach is to split the work
among multiple specialist organisms that can stably co-exist with each other. This approach
reduces the metabolic load and number of functionalities that must be optimized in one
organism.
1.2.2 Microbial consortium approaches for CBP
Natural microbial consortia capable of efficient (50-90%) lignocellulose degradation
have been identified. These consortia largely extract all the available energy since accumu-
lation of molecules that can serve as fuels invites exploitation by an additional consortia
member. Most of the resulting products (e.g., organic acids, CO2, CH4) of naturally oc-
curring consortia are not directly utilizable as liquid fuel [41]. Recent progress in the in-
vestigation of natural cellulose-degrading consortia includes identification of a thermophilic
community capable of producing 2 g/L ethanol from 7 g/L cellulose. Upon optimizing the
population composition, the ethanol titer was increased to 2.5 g/L, 78% of the theoretical
yield [42]. However, natural consortia tend to involve large numbers of minimally character-
ized species, making them difficult to adapt to an industrial application aimed at producing
a specific product. The challenge is thus to develop well-defined microbial consortia in which
the electron transfer cascade stops short of completion, with some energy captured in fuel
molecules [41,43].
Although today’s bioprocessing industry is dominated by monoculture systems, there
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is growing interest in using microbial consortia for applications including biofuel produc-
tion, bioremediation, lipid production, and biopolymer production. Advances in engineering
and analysis methods are increasing the viability of this type of technology. New tools,
reviewed in [44] and [45], include high-throughput screening methods for evaluating popula-
tion composition [46], hydrogel encapsulation [47, 48], and techniques for culture condition
optimization [49,50].
Various approaches exist for splitting the work of lignocellulosic biofuel production
among different microorganisms. One approach that has been taken is engineering specialist
strains to secrete cellulolytic enzymes that act synergistically. Tsai et al. [51] engineered
a four-strain S. cerevisiae consortium to produce a mini-cellulosome that enabled growth
and ethanol production on phosphoric acid swollen cellulose. Each of the strains produces
one recombinant protein - three cellulases with docking tags, and a scaffold. When the
population composition of the consortium was optimized via inoculation ratio, it produced
ethanol at yields of up to 0.475 g/g (93% of theoretical) and titer of 1.87 g/L ethanol.
Another approach is to combine a cellulolytic specialist that produces the enzymes
for saccharification and a fermentation specialist that produces the fuel molecule from the
soluble saccharides. Several proof of concept studies have demonstrated the feasibility of
this approach. For example, Zuroff et al. [43] have constructed an anaerobic consortium of
the cellulolytic Clostridium phytofermentans and fermentative S. cerevisiae. The yeast pro-
tected the C. phytofermentans from oxygen and symbiosis could be induced by controlling the
volumetric transport rate of oxygen. This system reached 22 g/L ethanol from 100 g/L mi-
crocrystalline cellulose but required externally produced endoglucanase. Brethauer & Studer
have used a multi-species biofilm membrane (MBM) setup to co-culture Trichoderma reesei,
an aerobic cellulolytic fungus, Scheffersomyces stipitis, a natural pentose fermenter under
microaerophilic conditions, and S. cerevisiae, an efficient hexose fermenter under anaerobic
conditions [52]. The MBM enabled the species to self-assemble into layers, each receiving the
appropriate oxygen content. This system achieved 67% of the theoretical yield on pretreated
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wheat straw with added β-glucosidase enzyme.
Minty et al. [53] have also taken a saccharolytic/fermentation division of labor ap-
proach, developing a stable dual member aerobic consortium for conversion of cellulosic
biomass into isobutanol. Isobutanol has a higher energy content, lower vapor pressure, and
lower hygroscopicity than the “first generation” biofuel, ethanol. Unlike ethanol, which
must be blended with gasoline, isobutanol is compatible with current engines and infrastruc-
ture [54].
The cellulolytic specialist of this system is T. reesei strain RUT-C30, a strain devel-
oped to hypersecrete cellulase enzymes that is widely used industrially and academically [55].
The fermentation specialist is one of several E. coli strains engineered by the Liao group
to produce isobutanol from glucose via the combination of the branched-chain amino acid
biosynthesis pathway with two heterologous Ehrlich pathway steps. The strain NV3 was
created for isobutanol production by random mutagenesis and selection on norvaline, a va-
line/leucine analog, the presence of which requires the cells to increase branched-chain amino
acid production for survival [11]. NV3r1 is a derivative of NV3 in which a mutation to the
gene encoding RpoS, an important stationary phase transcriptional regulator which helps
the cell survive stress, was repaired. Under ideal conditions these strains can produce isobu-
tanol with 59% (NV3) or 76% (NV3r1) yield of the theoretical maximum from glucose, the
latter being one of the highest reported for candidate next-generation biofuels [11].
The co-culture (with E. coli strain NV3) achieved up to 1.88 g/L isobutanol and yields
up to 62% of the theoretical maximum on ammonia fiber expansion (AFEX) pretreated corn
stover in minimal medium without any enzyme supplementation [53]. In an investigation
of potential limiting factors, it was found that plasmid loss is quite significant and likely a
limiting factor of culture performance (Fig 1.6).
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Figure 1.6: Plasmid loss over time in T. reesei/E. coli cocultures. Reproduced from [53].
1.3 Chromosomal integration and expression optimization in Es-
cherichia coli
1.3.1 Benefits of pathway integration
Although many metabolic engineering efforts are conducted using plasmids due to the
ease of manipulation, for industrial production strains it is highly desirable to have pathway
or recombinant protein genes stably integrated into the genome. Chromosomal integration
eliminates the need for the use of antibiotics for plasmid maintenance, which is desirable
for cost reasons and also to avoid the spread of antibiotic resistance. However, with current
methods, it is difficult to predict genomic expression levels of synthetic constructs. Tech-
niques for chromosomal integration and expression level optimization are reviewed in [56].
Generally, chromosomal expression is lower than desired. Methods to increase expression in-
clude the use of a strong promoter [57,58] or increasing copy number [59–61]. Chromosomal
location choice has also been explored since expression level at different sites can vary signif-
icantly [61,62]. More work is needed to elucidate the best strategies for choosing integration
location and optimizing expression level from the genome.
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1.3.2 Isobutanol pathway integration
Some work has already been done to develop strains with chromosomally integrated
isobutanol pathways. Akita et al. [63] integrated the isobutanol pathway into the genome
under xylose inducible promoters, with genes in several different genomic locations, and used
the strains to produce isobutanol from Japanese cedar hydrolysate without the addition of
antibiotics or exogenous inducer molecules. These strains reached 66% of the theoretical
yield on glucose/xylose and 14% on hydrolysate. Bassalo et al. [64] have also demonstrated
a chromosomally integrated isobutanol pathway, with the whole pathway in one location, but
production level was low (2.2 g/L isobutanol from 85 g/L glucose). Further optimization of
expression levels can presumably increase yields and titers.
1.4 Dissertation overview
This dissertation presents the development of a new high-throughput screening plat-
form utilizing cross-feeding auxotrophic biosensors. It then describes the utilization of the
screening method, as well as other strategies, to develop chromosomally integrated isobutanol
production strains. It also describes strategies to improve the T. reesei/E. coli consolidated
bioprocess developed by Minty et al. [53]. The chapters are as follows:
Chapter 1: Background and motivation: This chapter discusses the motivation for novel
high-throughput screening methods, consolidated bioprocessing for lignocellulosic biofuel
production, and chromosomal integration of heterologous genes.
Chapter 2: Development of Syntrophic Amplification of Production Phenotype (Sno-
CAP) screening platform: This chapter describes the development and testing of a screening
strategy based on a cross-feeding metabolic circuit. It demonstrates implementation in mi-
crotiter plates.
Chapter 3: Higher-throughput formats of SnoCAP: This chapter describes the imple-
mentation of SnoCAP in a colony screening assay and a microdroplet co-cultivation and
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sorting assay. It also details the screening of a chemically mutagenized library to find strains
with improved 2-ketoisovalerate production based on genomic expression rather than path-
way overexpression on a plasmid.
Chapter 4: Development of E. coli strains with chromosomally integrated isobutanol
pathway: This chapter describes the use of chemically inducible chromosomal evolution
[59] to produce strains with multiple copies of the kivd and adhA. It also discusses the
construction and screening of a library in which alsS is integrated into random sites in the
genome via transposon in order to achieve varying expression levels.
Chapter 5: Strategies for improving fungal-bacterial co-culture for more efficient con-
solidated bioprocessing: This chapter describes efforts to improve the T. reesei/E. coli by
deletion of competing pathways in the E. coli strain and preliminary work toward adaptive
evolution of T. reesei/E. coli co-cultures.
Chapter 6: Concluding remarks and perspectives: This chapter concludes the disser-
tation and describes potential future directions.
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Chapter 2: Development of Syntrophic Amplification
of Production phenotype (SnoCAP) screening platform
2.1 Introduction
Advances in genome engineering design and construction technologies have enabled
rapid generation of diverse microbial strains that efficiently explore the genotype space [65].
Characterizing these strains, however, is often a bottleneck in the design-build-test cycle
of synthetic biology. In particular, concerning the development of strains for production of
many target molecules, increasingly large and complex strain libraries can be created, yet the
throughput of screening for identifying top-performing variants is limited, sometimes lagging
several orders of magnitude behind the construction phase. Traditionally, for molecules that
lack chromogenic or fluorescent properties, metabolic engineers must rely on chromatography
or mass spectrometry quantification. Automation can help to increase the throughput of
these assays, but they have high capital investment and space requirements. Biosensor-
based high-throughput screenings seek to address this challenge by converting target molecule
production level into a conspicuous phenotype such as growth or fluorescence, either within
the production cell itself or in a partner strain. The latter approach enables the sensing of
extracellular secretion levels and reduces the interference between the production and sensing
functionalities. The sensing machinery generally consists of proteins, nucleic acid molecules
or whole cells that respond to the target molecule in a dose-dependent manner and produce
a detectable read-out [15,17,66].
One class of whole-cell biosensor consists of auxotrophic strains which are unable to
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produce an essential metabolite and whose growth characteristics, therefore, change in re-
sponse to changing concentrations of the target molecule in the surrounding environment.
Auxotrophic microbial strains have been identified or constructed and utilized as biosensors
for a variety of metabolites including amino acids [21–25], vitamins [26], and hormones [27].
Pfleger et al. applied auxotrophic biosensors to high-throughput screening of production
strain libraries by developing a fluorescent mevalonate auxotroph whose growth reports on
production strain performance [28]. Tepper & Shlomi [67] have established a computational
framework to predict gene deletions that can be used to produce auxotrophic strains for
use as biosensors. For Escherichia coli, for instance, they predict 53 molecules for which
auxotrophic biosensor strains could be created. Furthermore, for molecules for which no
auxotrophic biosensor is available, they present a strategy to engineer the producer strain
by gene knockout so that production of the target molecule is coupled to that of a proxy
metabolite, for which a biosensor does exist.
Despite the array of auxotrophic biosensors available, a limitation in applying them to
high-throughput screening is that they generally have narrow dynamic ranges, confined to
low concentrations of the focal molecules. Thus, although these molecules are essential for
growth, they do not directly confer a selective advantage if the strains are producing more
than small quantities of the molecule. This small dynamic range limitation can sometimes
be overcome by dilution of the samples [28,68], but this makes screening more cumbersome,
lowering throughput.
Here, we describe the utilization of auxotrophic strains in a cross-feeding circuit for
Syntrophic Co-culture Amplification of Production phenotype (SnoCAP) that enables high-
throughput screening of production strains via colocalization with a partner strain (Fig.
2.1). One strain, the ”sensor”, is auxotrophic for the target molecule; its ability to grow
depends upon the amount of target molecule excreted by the other strain, the ”secretor.” The
secretor is auxotrophic for an orthogonal molecule supplied by the sensor strain. In model
microbial systems, it has been shown that changes in the secretion or uptake characteristics
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of either partner of a cross-feeding pair determine the resulting composition of the co-culture
as well as its overall co-growth rate [69,70]. We predict that a secretor strain with improved
production rate will lead to faster growth and an increased final sensor-to-secretor ratio
(Fig. 2.1A). The strategy requires compartmentalization of secretors of unique genotype
with the sensor strain and we have implemented this in several formats (Fig. 2.1B). In this
chapter, we use confinement in wells of 96-well microtiter plates. Higher throughput formats
(colony screening on agar plates and microdroplet co-cultivation and sorting) are explored
in Chapter 3.
The majority of the work presented in this chapter has been submitted for publication
as a manuscript titled “Syntrophic co-culture amplification of production phenotype for high-
throughput screening of microbial strain libraries.” Authors: T. E. Saleski, A. R. Kerner,
M. T. Chung, C. M. Jackman, A. Khaasbaatar, K. Kurabayashi, X. N. Lin.
2.2 Results
2.2.1 Model-based prediction of amplification of production improvement via
metabolic cross-feeding circuits
Kerner et al. [69] presented an ODE model of a cross-feeding co-culture in its exponen-
tial growth phase, assuming constant secretion and uptake parameters and Monod kinetics
for growth on a limiting nutrient (i.e., the amino acid for which the strain is auxotrophic).
In this model, the co-culture reaches a pseudo-steady-state in which the two strains have the
same growth rate (µ, unit: 1/hr), which depends on each auxotroph’s secretion rate (αSec,
αSens; unit: mmol/gDM-hr) of its shared metabolite and the per cell growth requirements for
the cross-fed metabolites (βSec, βSens; unit: mmol/gDM). Additionally, a steady population
composition ratio (r) between the number of each cell type (NSec, NSens) is reached.
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Figure 2.1: Overall schematic of screening strategy. (A) Production improvement leads to increased
co-growth and increased final sensor-to-secretor ratio. ∆t represents a change in time. The purple
star represents the molecule that one wishes the secretor strain to overproduce. The blue triangle
represents a secondary cross-fed metabolite. (B) Expected amplification of secretion improvement
by co-culture growth. A production strain with 50% improvement compared to a base strain
will lead to a co-culture with 4.7 times as many cells as that of the base strain (370% more)
after a time corresponding to 10 doublings of the base co-culture. This is a 7.5-fold amplification
of the percentage improvement (point A). After 25 doublings of the base strain co-culture, this
amplification will rise to 96-fold (point B). For a smaller improvement of 5%, there will be 1.2 times
as many cells in the improved secretion co-culture after 10 base doublings, a 3.7-fold amplification
(point C). After 25 doublings of the base co-culture, this will increase to a 10.7-fold amplification
(point D). (C) Screening implementation formats explored in this study: separating secretor cells
of unique genotype by compartmentalization in wells of microplates, spatial separation on agar
plates, or confinement in microdroplets. After growth, secretor strains are isolated from well-grown
co-cultures for further analysis in monocultures.
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Mathematically, these properties are given by:
µ =
√
αSecαSens/(βSecβSens) and r =
√
αSecβSec/(αSensβSens).
Thus, if the secretion rate of the secretor (αSec) increases and all else remains un-
changed, we expect the co-culture growth rate to increase and the percentage of the final
population that is the sensor to increase. If we have a base-level secretor strain with secre-
tion rate αBase and an improved secretor with secretion rate αBase(1 + x) and we grow each
secretor with the sensor strain, the exponential growth of the co-culture quickly amplifies
even moderate differences in production level (Fig. 2.1C). After an amount of time corre-
sponding to n doublings of the base strain co-culture, the improved secretor’s co-culture will
have 2n(
√
1+x−1) times as many cells as the base strain’s co-culture.
At some high enough αSecNSec such that the target molecule is no longer limiting for
the sensor strain, this model breaks down. There is then one-directional feeding where the
sensor can grow without further growth of the secretor strain. In this case, the maximum
growth rate may not be increased for a higher producing strain, but the time to reach this
critical value of αSecNSec will vary for secretor strains with different αSec production rates.
We, therefore, expect that, over some range of secretion levels, improvements in secretor
strain production will lead to detectable changes in co-culture growth and composition.
2.2.2 Development of two model systems: 2-ketoisovalerate and tryptophan
We first demonstrated the SnoCAP screening framework using 2-ketoisovalerate (2-
KIV) as a target molecule. 2-KIV is a precursor of the branched-chain amino acids valine and
leucine. By overexpression of an alpha-ketoisovalerate decarboxylase (Kdc) and an alcohol
dehydrogenase (Adh) in E. coli, 2-KIV can be converted into the drop-in biofuel isobutanol.
Additional overexpression of three enzymes that catalyze the conversion of pyruvate to 2-KIV
leads to substantially improved isobutanol production [10] (Fig. 2.2A, B).
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Figure 2.2: Co-culture growth characteristics correlate with monoculture production performance.
(A) 2-KIV and isobutanol production pathway. Genes that are overexpressed in the production
strains are boxed in the color corresponding to the strain in the legend in (B). (B) Monoculture
production characteristics of three different secretor strains carrying pSA65 (PLlacO1::kivd–adhA).
Isobutanol, glucose and cell growth profiles are shown. Error bars represent the standard deviation
of four biological replicates. Growth profiles of co-cultures of the same three secretor strains (not
carrying pSA65) with sensor strain K12 ∆ilvD::kan in a microplate with (C) and without (D)
IPTG-induced expression of the alsS/ilvCD genes. Three replicate wells are shown for each strain
pair, plotted in the same color. (E) Co-culture growth rates. Error bars represent the standard
deviations between at least 10 biological replicates, combined from two separate experiments. (F)
Population composition of microplate cultures in early stationary phase. Error bars represent
standard deviations from two biological replicates with two technical replicates each.
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We chose a ∆ilvD auxotroph as the sensor strain. IlvD, dihydroxy-acid dehydratase,
catalyzes the conversion of 2,3-dihydroxy-isovalerate into 2-KIV. IlvD is also part of the
isoleucine biosynthesis pathway, catalyzing the conversion of 2,3-dihydroxy-3-methylvalerate
into 2-keto-3-methylvalerate. We therefore supplemented the co-cultures with an excess of
isoleucine in order to eliminate effects from variation in isoleucine cross-feeding levels. When
grown with excess isoleucine and varying levels of 2-KIV, the ilvD auxotroph’s growth rate
and maximum cell density increase in response to increasing 2-KIV over a certain range (Fig.
2.3A, B).
For a given E. coli auxotroph, a variety of cross-feeding partner auxotroph options are
generally available, exhibiting a range of co-culture growth rates [34,35]. We tested a panel
of potential partner auxotrophic strains for their ability to cross-feed with K12 ∆ilvD in a
minimal medium supplemented with isoleucine. Of the partner auxotrophs tested (∆hisD,
∆leuB, ∆lysA, ∆pheA, ∆ppC, ∆trpB, and ∆tyrA, each in strain BW25113), ∆lysA (a lysine
auxotroph) and ∆pheA (a phenylalanine auxotroph) showed consistent growth (Fig. 2.4).
Both showed considerable lag phases (∼2 and 5 days, respectively) and lower maximum
optical densities than monocultures, leaving room for improved secretion to boost co-culture
growth. We chose to proceed with lysine as the secondary cross-fed molecule. Selecting
a different auxotroph, including ones that have no growth with the base production-level
strain, may be a useful strategy to adjust the dynamic range of the screening.
We tested the growth properties in 96-well microplates of sensor strain K12 ∆ilvD in
co-culture with secretor strains of several different secretion levels. Genotypes of these strains
are listed in Table S1. JCL16 ∆lysA is the base strain, with a low production level. JCL260
∆lysA alsS, which has six gene deletions to direct flux through the isobutanol pathway
and a single copy of alsS, under an IPTG-inducible promotor, integrated into the genome,
represents an intermediate-production-level strain. JCL260 ∆lysA pSA69, which has the
same gene deletions and carries a plasmid for overexpression of alsS and ilvCD under an
IPTG-inducible promotor, represents a high-production-level strain. When transformed with
22
Figure 2.3: Sensitivity of K12 ∆ilvD sensor growth characteristics to 2-KIV concentration in mono-
culture. (A) Growth profiles of the K12 ∆ilvD sensor strain. The medium contains an excess of
isoleucine. Three replicate wells are plotted in the same color for each 2-KIV concentration. (B)
Maximum OD600 and growth rate from the growth profiles in (A).
pSA65, which carries kivD/adhA, and grown in monoculture fermentations, these strains have
differing levels of isobutanol production and glucose consumption, and similar growth profiles
(Fig. 2.2B). We inoculated these strains (lacking pSA65) in co-culture with the sensor strain
at a 1:1 initial ratio in minimal medium with isoleucine. Monoculture inoculation of any
of these strains or the sensor strain in this medium produces no detectable growth. In the
co-cultures (Fig. 2.2C), growth order and growth rate (Fig. 2.2E) increases with increasing
strain production level. Addition of IPTG results in a higher growth rate for co-cultures
with each of the strains carrying an IPTG-inducible operon (either alsS only or alsS-ilvCD),
and no difference for base strain JCL16 (Fig. 2.2D, E). This indicates that expression of
Figure 2.4: Co-culture growth profiles of various Keio strains with K12 ∆ilvD. Biological replicates
are plotted in the same color (n = 4). Legend denotes the gene knockout of the Keio strain.
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Figure 2.5: Z-factors over time for the microplate assay. Z-factors were calculated from the OD600
readings of co-cultures containing secretor strain JCL16 ∆lysA as negative control and JCL260
∆lysA pSA69 as positive control (8 replicates each; medium containing 0.1 mM IPTG and no
norvaline). The Z-factor is defined as Z = 1− (3σp + 3σn)/(|µp−µn|), where µ and σ are the mean
and standard deviation of the positive (p) and negative (n) controls.
the genes leading to 2-KIV translates into increased growth in the co-culture setting. We
determined the composition of the co-cultures when in early stationary phase by differential
plating (see Materials and methods). As predicted, the sensor-to-secretor strain ratio rises
with increasing production level of the secretor strain (Fig. 2.2F).
To evaluate the suitability of the cross-feeding co-culture growth assay for high-throughput
screening, we calculated the Z-factor, a parameter that reports on a combination of the signal
dynamic range and assay precision [71]. The Z-factor is defined as Z = 1−(3σp+3σn)/(|µp−
µn|), where µ and σ are the mean and standard deviation of the positive (p) and negative (n)
controls and values between 0.5 and 1.0 are considered indicative of an excellent assay. We
considered co-cultures containing secretor JCL16 ∆lysA as the negative control and JCL260
∆lysA pSA69 as the positive control and found that the Z-factor was in the “excellent” range
from hours 11 to 62 of the assay period (Fig. 2.5). This analysis indicates that the assay
can be quite effective at identifying improved variants at times before the parent strain has
produced co-growth.
As a second test case of the SnoCAP screening framework, we examined tryptophan-
producing strains. For this implementation, we chose BW25113 ∆trpB, which lacks the
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Figure 2.6: Implementation of the SnoCAP screening method for tryptophan production. Plots
show co-culture growth in 96-well microplates with different initial amino acid supplementation.
Three biological replicates are shown for each strain, plotted in the same color. The inset shows
the scheme of tryptophan/histidine cross-feeding.
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catalytic subunit of tryptophan synthase, as the sensor strain. We selected histidine as
the secondary cross-fed molecule (Fig. 2.6, inset), based on work showing that growth of
tryptophan/histidine cross-feeding co-cultures is affected by overproduction of tryptophan
[72]. For overproduction strains, we deleted the trpR and tnaA genes, both individually and
sequentially in the same strain. Deletion of these genes, which encode a repressor of the
trp operon and a tryptophanase, respectively, are typical early steps in the engineering of
tryptophan production strains (e.g., [73, 74]). In liquid co-cultures in microplates, all three
modified strains had increased co-culture growth compared to the base strain. However,
the growth took several days to be observable. Since these deletions are only first steps in
tryptophan strain engineering, it may be useful that these strains’ co-growth is slow, since it
leaves substantial room for improvement with higher production-level strains. Nevertheless,
we were also interested in determining whether we could decrease assay time while still
maintaining the detectable differences in growth phenotype between the higher production-
level strains and base strain. We added low levels of histidine and tryptophan to jump-start
the co-cultures and found that addition of histidine produced the desired effect (Fig. 2.6).
Biphasic growth was observed in many of these cultures (Fig. 2.6). It is not imme-
diately obvious what leads to this phenomenon, but one possibility is that tryptophan has
started to accumulate in the medium and this changes the dynamics of the culture. Analy-
sis of the culture composition by fluorescent labeling or by differential plating may provide
insights into what is occurring.
2.2.3 Increasing the dynamic range by utilization of an inhibitory analog of the
target molecule
One common issue in previous biosensor-based screening is the limited dynamic range
of production level. We hypothesized that the addition of an inhibitory analog of the target
molecule could expand the dynamic range of screening significantly and increase differences of
co-culture growth in the SnoCAP framework. Analog selection, in which bacteria are grown
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on an inhibitory analog of a metabolite in order to select for overproduction of that metabo-
lite, is a useful strategy for strain development and has been used to identify mutations that
overexpress pathway genes or decrease feedback inhibition from target molecules [75, 76].
A computational framework has recently been developed to identify candidate metabolite
analogs for use in strain improvement [77].
Norvaline, a toxic analog of valine and leucine, has been used as a selection agent for
increased flux through the valine [75] and isobutanol [11] pathways. Norvaline produces
a growth defect that can be partially recovered by the addition of either leucine or valine
alone or fully recovered by addition of both leucine and valine (Fig. 2.8A). We first verified
that the sensor strain’s growth remains responsive to increasing 2-KIV in the presence of
norvaline (Fig. 2.7A, B). We then added norvaline to the co-cultures and found that
its addition magnifies differences between the strains at the higher end of the production
spectrum (Fig. 2.8B). For low levels of norvaline, the co-cultures with JCL260 ∆lysA pSA69
as the secretor strain are not affected by the norvaline, while those with JCL260 ∆lysA alsS
exhibit an increasing lag phase time with increasing norvaline concentration. For higher
levels of norvaline, such as 1.0 g/L, co-cultures with JCL260 ∆lysA pSA69 show lengthening
lag phase as well. Thus, norvaline can be used to expand the dynamic range and increase
the production threshold below which secretor strains cannot support co-culture growth.
It is also interesting to note that, because the co-culture growth characteristics are
determined primarily by production levels, the SnoCAP screening framework can avoid or
mitigate the issue of metabolic burden on cell growth caused by over-expression of synthetic
gene constructs, compared to direct screening with monocultures. For instance, although
pSA69 increases 2-KIV production, we observed that when its expression is induced with
IPTG, the growth of the strain in norvaline is decreased (Fig. 2.8B).
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Figure 2.7: Sensitivity of K12 ∆ilvD sensor growth characteristics to 2-KIV concentration in mono-
culture with norvaline. (A) Growth profiles with 1.0 g/L norvaline. The medium contains an excess
of isoleucine. Three replicate wells are plotted in the same color for each 2-KIV concentration. (B)
Maximum OD600 and growth rate from the growth profiles in (A).
Figure 2.8: Norvaline as a tool to expand assay dynamic range. (A) Growth profiles of JCL16
∆lysA supplemented with 3 mM lysine and 3 mM isoleucine with and without 1.0 g/L norvaline,
3 mM valine, and 3 mM leucine. Three biological replicates of each culture are plotted in the
same color. (B) Liquid co-cultures with various levels of norvaline. (C) Liquid monocultures on
1.0 g/L norvaline, demonstrating that norvaline is not an effective selection tool for these strains
in monoculture.
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2.2.4 Application of an intermediate-sensor assisted push-pull strategy to screen
for isobutanol production
Intermediate-sensor assisted push-pull strategy has been proposed as a general method
for screening for production of molecules that lack a direct sensor but for which a sensor
is available for an intermediate, and has been successfully demonstrated for deoxyviolacein
with a tryptophan biosensor [78]. This approach involves using the intermediate sensor to
screen for increased production of the intermediate and then improving the conversion of
intermediate to final product by screening for decreased readout from the biosensor. We
investigated whether SnoCAP can be employed in such a manner, i.e., whether increased
activity of a pathway converting the cross-fed molecule to a target molecule will decrease
the co-culture growth.
Using the 2-KIV system, we compared co-culture growth with secretor strain JCL260
∆lysA pSA69, a strain in which the pyruvate to 2-KIV part of the pathway performs well,
to that of secretor strain JCL260 ∆lysA pSA65/9, which additionally carries the 2-KIV to
isobutanol part of the pathway. We observed a significant decrease in co-culture growth
rate and increase in lag time for the pSA65 carrying strain (Fig. 2.9A). We also examined
intermediate levels of Kivd/AdhA expression in strains that contain copies of these genes
integrated into the genome. These strains were generated using chemically inducible chro-
mosomal evolution (CIChE), which enables the copy number of a construct of interest to be
adjusted by changing the concentration of a lethal chemical (e.g., chloramphenicol, to which
the resistance can be rendered by the integrated construct in a dose-dependent manner) in
the medium [59]. Using this method we obtained strains JCL260 ∆lysA cm 20 and JCL260
∆lysA cm 80. These strains have differing levels of isobutanol production (Fig. 2.9B). We
saw that with the lower levels of Kdc/Adh expression there is still a decrease in co-culture
growth but to a lower degree than with the high expression from pSA65 (Fig. 2.9C).
Because the addition of pSA65 adds metabolic burden and a toxic product, it was not
clear how much of the decrease in growth was indeed due to 2-KIV being channeled away
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Figure 2.9: Screening for conversion of 2-KIV into isobutanol. (A) Schematic of sensing interme-
diate. (B) Production levels of the four strains with differing levels of adhA/kivd expression in M9
minimal medium, 36 g/L glucose. (C) Liquid co-culture growth profiles of secretor strains carrying
varying levels of adhA/kivd expression.
from cross-feeding. We, therefore, tested these co-cultures under the condition of excess
leucine and valine instead of isoleucine. This condition leads to a co-culture that must cross-
feed isoleucine or intermediates for the production of isoleucine (Fig. 2.10A). If defects in
growth were due mainly to factors other than 2-KIV channeling, such as a metabolic burden
or product toxicity, then we would expect them to be observed under the leucine/valine
supplementation as well. Under the leucine/valine-supplemented conditions, we observed
some basal growth of the sensor strain monoculture, but the co-cultures have significantly
more growth. For both secretor strains tested (JCL260 ∆lysA alsS and JCL260 ∆lysA
pSA69), the version carrying pSA65 has reduced growth compared to that without pSA65
under the isoleucine-supplemented condition (Fig. 2.10C) and has similar growth to that
without pSA65 under the leucine/valine-supplemented condition (Fig. 2.10B). These results
support the prediction that the co-growth characteristics will be determined primarily by
the production level of the cross-fed molecules.
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Figure 2.10: Investigation of the cause of the reduced co-culture growth in strains with increased
alpha-ketoisovalerate decarboxylase and alcohol dehydrogenase activity. (A) Branched-chain amino
acid and isobutanol pathways. Co-culture and sensor strain monoculture growth profiles in liquid
medium supplemented with either 3 mM of both leucine and valine (B) or 3 mM isoleucine (C).
2.3 Discussion and conclusion
In this chapter, we have developed the SnoCAP framework for converting inconspicuous
production phenotypes into growth phenotypes, facilitating high-throughput screening of
production strain libraries via compartmentalization of cross-feeding production and sensor
strains. The use of metabolite analogs makes the assay dynamic range highly tunable without
requiring any genetic modifications. The tunability could be further improved by making
genetic modifications to the sensor strain, such as adjusting the production rate of the
secondary cross-fed molecule. We also demonstrate that the assay timing can be adjusted by
kick-starting the culture with low-concentrations of the cross-fed metabolites. Since assay
readout is cell density or cell fluorescence, no costly assay reagents are necessary. We have
shown the utility of this method for screening strain libraries and identified a strain that
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overproduced 2-KIV without a plasmid, which is desirable since plasmids require antibiotics
for maintenance, and even then may still be lost under non-ideal conditions [53].
As proofs of concept, we explored SnoCAP for screening production of 2-KIV, which
can be converted into the drop-in biofuel isobutanol, and the amino acid tryptophan. We
expect that the SnoCAP screening framework can be applied to a wide variety of industrially
relevant target molecules for which auxotrophic strains exist or can be constructed. Amino
acid precursors that can be converted into other alcohols of interest (Fig. 1.1A) would also
be interesting to explore. We also expect that this technology can be applied to various
other microbial species. Synthetic cross-feeding consortia have been examined in yeast [79],
and E. coli has shown the ability to cross-feed with other species, such as Acinetobacter
baylyi [72] or Salmonella species [33, 80]. The strategy could also be extended to screening
for overproduction of other compounds of interest that a strain with a diverse metabolism,
such as Pseudomonas putida, can utilize as a carbon source but the secretor strain cannot.
In this case, a carbon source would be supplied to the secretor that the sensor cannot utilize.
Since many microbes have naturally occurring auxotrophies, there are likely cases where the
secondary auxotrophy does not even require genetic modification of the secretor strain.
2.4 Materials and methods
2.4.1 Strains and plasmids
Strains and plasmids used are listed in Tables 2.1 and 2.2, respectively. JCL16,
JCL260, pSA65 and pSA69 [10, 81] were provided by James Liao, UCLA. Keio strains were
obtained from the E. coli genetic stock center (CGSC, http://cgsc2.biology.yale.edu/). The
pTGD plasmid [59] was provided by Keith Tyo, Northwestern University.
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2.4.2 Gene deletions and insertions
Oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA) and
are listed in Table 2.3.
Gene deletions were constructed by P1 phage transduction as previously described
[82,83]. Keio strains were used as the donor strains and LB agar with 50 µg/mL kanamycin
was used as the selective medium. Transductants were purified from residual P1 phage by
isolation streaking on LB agar supplemented with 0.8 mM sodium citrate and 50 µg/mL
kanamycin and verified by colony PCR as described previously [83]. When required, the
FRT-flanked kanamycin resistance gene used for selection was removed by transformation
with a temperature-conditional plasmid, pCP20, expressing FLP-recombinase from a ther-
moinducible promoter.
To integrate the alsS gene into the site between yghX and gpr, the region of pSA69
containing kan and PLlacO1-alsS was amplified using primers alsS yghX int for and
alsS yghX int rev, which contain 50 bp overhangs that add homology to the E. coli genome
between yghX and gpr (location selected based on [63]). The PCR product was digested with
both DpnI and SpeI for 12 h to degrade plasmid DNA. The remaining linear construct was
integrated into JCL260 ∆lysA::FRT harboring pSIM6 by λ-Red recombineering, following
published protocols [84].
The adhA and kivd genes were amplified from the pSA65 plasmid using primers
pstI adhA kivd for and mluI adhA kivd rev. The product was DpnI digested to degrade
residual template plasmid and cloned into the pTGD plasmid using restriction enzymes PstI
and MluI. pTGD provides a chloramphenicol resistance cassette and flanking 1 kb homology
regions to enable CIChE. The CIChE construct was then amplified from the resulting pTGD-
adhA-kivd using aslB integr for and aslB integr rev, which add 40 bp regions of homology
to the aslB locus of the E. coli genome. After DpnI digestion, the linear construct was
integrated into NV3r1 by λ-Red recombineering using pSIM6 [84] with selection on LB plates
with 20 µg/mL chloramphenicol. A resulting integrant (named NV3r1 cm 20) was verified
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by PCR and Sanger sequencing. Subsequently, CIChE was performed by growing NV3r1 cm
20 to saturation and passaging into in successively higher concentrations of chloramphenicol
(cells were passed 1% v/v and antibiotic concentration was doubled in each passage). To
construct JCL260 cm 20 ∆lysA pSA69 and JCL260 cm 80 ∆lysA pSA69 we prepared P1
lysates from NV3r1 cm 20 and NV3r1 cm 80 and transduced them into JC260 ∆lysA::FRT
pSA69, selecting on LB plates with 10 µg/mL tetracycline, 50 µg/mL kanamycin and the
corresponding concentration of chloramphenicol (20 or 80 µg/mL). Resulting colonies were
isolation streaked twice on LB agar with the same antibiotics and 0.8 mM sodium citrate.
2.4.3 Cell preparation for SnoCAP screening
Strains were maintained as glycerol stocks at -80 oC and streaked from cryostocks on
LB agar plates with the appropriate antibiotics. Colonies were then picked into liquid LB
Lennox with appropriate antibiotics and grown to stationary phase (16-18 h, 37 oC, 250
rpm). For microtiter plate assay, the stationary phase cells were harvested in 1 mL aliquots
by centrifugation at 12,000 g for 1 min. The cells were washed twice with 1 mL of 1x M9 salts
without amino acids and resuspended to an optical density corresponding to ∼109 CFU/mL
based on OD600 measurement in a VersaMax microplate reader (Molecular Devices).
2.4.4 Media
M9IPG, consisting of M9 salts (47.8 mM Na2HPO4, 22.0 mM KH2PO4, 8.55 mM NaCl,
9.35 mM NH4Cl, 1 mM MgSO4, 0.3 mM CaCl2), micronutrients (2.91 nM (NH4)2MoO4,
401.1 nM H3BO3, 30.3 nM CoCl2, 9.61 nM CuSO4, 51.4 nM MnCl2, 6.1 nM ZnSO4, 0.01
mM FeSO4), thiamine HCl (3.32 µM) and dextrose (D-glucose) at the stated concentrations,
was used as the base medium. When specified, 5 g/L yeast extract was added to the medium.
Antibiotics were used at the following concentrations: ampicillin, 100 µg/mL; kanamycin,
50 µg/mL; tetracycline, 10 µg/mL; chloramphenicol, 20 or 80 µg/mL. All amino acids were
the enantiopure L-isomer, except for norvaline, which was a racemic form (Thermo Fisher
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Scientific).
2.4.5 Co-growth assay in microplates
M9IPG with 20 g/L glucose, 3 mM isoleucine, and 50 µg/mL kanamycin was used for all
microplates in the 2-KIV screen. No other antibiotics were added. When noted, the medium
contained IPTG at 0.1 mM concentration. M9IPG with 4 g/L glucose and no antibiotics
were used for all microplates in the tryptophan screening system. When noted, cultures
were supplemented with the stated concentrations of tryptophan and histidine. Cells were
prepared as described above and then inoculated into the medium. For monocultures, the
cells were inoculated 1:100 by volume unless otherwise specified. For co-cultures, each strain
was inoculated 1:200 by volume. Cultures were vortexed and then distributed into a 96-well
clear microplate (Brand), 200 µL per well. Microplate lids were coated with a solution of
0.5% Triton X-100 in 20% ethanol to reduce condensation and lids were fastened with tape.
Microplates were incubated at 37 oC, with shaking in a VersaMax plate reader (Molecular
Devices), with absorbance readings at 600 nm taken every 10 min. µmax was calculated via
linear regression of natural log of OD600 values (after subtracting blank values) vs. time;
regression was performed over the time intervals corresponding to early exponential growth
phase.
2.4.6 Cultivation for isobutanol production assay
Production assessment was performed similarly to previous studies (e.g., [10]). Overnight
cultures in LB with appropriate antibiotics were diluted 1:100 v/v into 10 mL of M9IPG
with 36 g/L glucose, 100 µg/mL ampicillin, and 50 µg/mL kanamycin in a 125 mL baf-
fled, unvented polypropylene flasks. The medium was supplemented with either 5 g/L yeast
extract or 3 mM lysine. Cells were grown to early exponential phase at 37 oC, 250 rpm,
followed by addition of 0.1 mM IPTG. Flasks were then sealed with parafilm and incubated
at 30 oC, 250 rpm.
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2.4.7 Metabolite detection
Isobutanol and glucose concentrations were assessed by applying filtered culture broth
to a Shimadzu high-performance liquid chromatograph (HPLC; model DGU 20A3R) equipped
with an autosampler, Phenomenex Rezex ROA Organic Acid H+ (8%) guard and analytical
columns (5 mM H2SO4; 0.6 ml/min; column temperature, 60
oC), and a refractive index
detector.
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Table 2.1: Strains employed in the studies described in Chapter 2
Strain Relevant genotype Reference
JCL16 BW25113/F′[traD36, proAB+, lacIq Z∆M15 (TetR)] [10]
JCL260 JCL16 ∆ldhA ∆frd ∆adhE ∆pta ∆fnr ∆pflB [10]
JCL16 ∆lysA JCL16 ∆lysA::kan This study
JCL260 ∆lysA JCL260 ∆lysA::kan This study
JCL260 ∆lysA alsS JCL260 ∆lysA::FRT with PLlacO1::alsS integrated
between yghX and gpr
This study
JCL260 ∆lysA pSA69 JCL260 ∆lysA::FRT pSA69 This study
JCL260 cm X JCL260 ∆lysA::FRT with adhA-kivd CIChE
construct integrated in the yihG site, maintained
both on plates and in liquid medium with X mg/mL
chloramphenicol
This study
K12 ∆ilvD K12 ∆ilvD ::kan This study
∆trpB Keio strain BW25113 ∆trpB::kan (JW1253-1) CGSC
K12 ∆hisD K12 MG1655 ∆hisD::kan This study
K12 ∆hisD ∆trpR K12 MG1655 ∆hisD ::FRT ∆trpR::kan This study
K12 ∆hisD ∆tnaA K12 MG1655 ∆hisD ::FRT ∆tnaA::kan This study
K12 ∆hisD ∆trpR ∆tna K12 MG1655 ∆hisD ::FRT ∆trpR::FRT ∆tnaA::kan This study
∆hisD Keio strain BW25113 ∆hisD::kan (JW2002-1) CGSC
∆ilvD Keio strain BW25113 ∆ilvD::kan (JW5605-1) CGSC
∆ilvE Keio strain BW25113 ∆ilvE::kan (JW5606-1) CGSC
∆lysA Keio strain BW25113 ∆lysA::kan (JW2806-1) CGSC
∆ppc Keio strain BW25113 ∆ppc::kan (JW3928-1) CGSC
∆tnaA Keio strain BW25113 ∆tnaA::kan (JW3686-7) CGSC
∆trpB Keio strain BW25113 ∆trpB::kan (JW1253-1) CGSC
∆trpR Keio strain BW25113 ∆trpR::kan (JW4356-2) CGSC
∆tyrA Keio strain BW25113 ∆tyrA::kan (JW2581-1) CGSC
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Table 2.2: Plasmids used in the studies described in Chapter 2
Plasmid Relevant genotype Reference
pSA65 ColE1 ori; AmpR;
PLlacO1::kivd–adhA
[81]
pSA69 p15A ori; KanR;
PLlacO1::alsS–ilvC–ilvD
[10]
pSIM6 Red expression plasmid;
ampicillin-resistant
[84]
pTGD CIChE plasmid;
chloramphenicol- and ampicillin-
resistant
[59]
pTGD-adhA-kivd pTGD with PLlacO1::kivd–adhA
cloned in between the 1 kb
homology regions, using enzymes
PstI and MluI
This study
Table 2.3: Primers and oligos used in the studies described in Chapter 2
Name Sequence 5’ → 3’
p15a for TCTGACGCTCAAATCAGTGG
p15a rev AGGCGTGGAATGAGACAAAC
alsS yghX int for AATTTCGAAACAATGTTTCTAGTTTAGCGA
TTCGCCAGCGCGTATCCCGTACCGAGCG
TTCTGAACAAAT
alsS yghX int rev GCATAAGCACGTATTTTTGCCCAGTTTTTC
GTCACTCTGTGAGCCAGACTGGTGATTCC
TCGTCGACCTA
alsS int chk front for ACCTCTCCTTTCCACCGTTC
alsS int chk front rev TCGCCTTCTTGACGAGTTCT
alsS int chk back for GGGGAACTCATGAAAACGAA
alsS int chk back rev GAGATTTTCCCGTGAGCGTA
pstI adhA kivd for CTACTGCAGAATTGTGAGCGGATAACAAT
mluI adhA kivd rev AACTACGCGTACAACAGATAAAACGAAAGG
aslB integr for ATGCGTCAGCATCGCATCCGGCAAAGGCAG
ATC
TCAGCGACGAGGCAGCAGATCAATTCG
aslB integr rev CCACCACGCGCGCAGATTAAATCTGACTAAG
CCGGCGCTAGCTACGGCGTTTCACTTCTG
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Chapter 3: Higher-throughput formats of SnoCAP
3.1 Introduction
A microplate-based screen’s throughput can be extended by miniaturization and au-
tomation, but generally becomes limited by space and setup time to no more than∼104 assays
per experiment. Automation of the plate handling also requires costly specialized equipment.
We were therefore interested in exploring other formats of compartmentalization of individ-
ual secretor cells with the sensor strain. To this end, we investigated implementation as a
colony screening assay and as a microfluidic droplet assay.
The use of water-in-oil droplets as miniature bioreactors has long been an attractive
approach and dates back to at least the 1950s [85]. The development of droplet microfluidics
has led to high-throughput techniques for generation and manipulation of monodisperse
droplets. This has enabled high-throughput screening for a variety of applications, with low
space and reagent requirements. Use of droplet microfluidics for microbiology applications,
including biotechnology, is reviewed in [86]. Droplet sorting, either via microfluidic sorting
devices [87] or commercial flow cytometry, has proved effective at screening enzyme variant
libraries for directed evolution. It has also been applied to screening whole cell libraries
for production level. With current droplet sorting technology, the highest throughput of
sorting is achieved using fluorescence signal. Strategies for coupling strain production to
fluorescence for droplet screening have included encapsulation with oxidase enzymes and
horseradish peroxidase [88], encapsulation with a sensor strain with a transcription-factor
sensor [89], encapsulation with Spinach aptamers [90], inherently fluorescent products [91],
and staining with fluorescent dyes [92].
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To increase the throughput of SnoCAP, we have explored higher throughput com-
partmentalization strategies for the SnoCAP screening strategy presented in Chapter 1:
spatial separation on agar plates and encapsulation in water-in-oil microdroplets. While
microplate assays reach throughputs of 102-104 assays/experiment, these formats can reach
orders of higher throughputs (102-104 assays/experiment on agar plates, and 104-105 as-
says/experiment in microdroplets). The higher throughput formats also offer other advan-
tages, such as smaller space and capital cost requirements and shorter incubation times. We
applied the agar plate format of the 2-KIV screening to a library of chemically mutagenized
JCL260 ∆lysA alsS and identified a strain that can produce a 5-fold higher titer of isobu-
tanol than the parent strain. We sequenced the genome of this strain and identified potential
mutations that may contribute to the improved phenotype. We reconstructed a mutation in
the substrate binding loop of the aceK gene and determined that it led to a small but sta-
tistically significant improvement in isobutanol production. We then implemented SnoCAP
by co-cultivation in microfluidically generated droplets. We encapsulated model libraries
consisting of low percentages of the high-producing strain and demonstrated that we could
isolate the rare high-producers by fluorescent-activated droplet sorting (FADS).
The majority of this work has been submitted for publication, in the same manuscript
as Chapter 2.
3.2 Results
3.2.1 Implementation of co-culture screening in an agar plate format
We implemented SnoCAP as a colony-screening assay by spreading ∼107 CFU of the
sensor strain (enough to form a lawn were the cells able to grow in monoculture) and ∼100
CFU of secretor strain on agar medium in 10 cm diameter Petri dishes. This produced mixed
colonies, each originating from a single secretor cell. We verified that these colonies were
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indeed mixtures of secretor and sensor by streaking them on LB plates with IPTG/X-gal and
observing both blue (sensor) and white (secretor) colonies. We also observed no growth on
monoculture plates containing only one strain, demonstrating that colonies only form when
both sensor and secretor are present. We compared mixed colony formation between the
base strain (JCL16 ∆lysA) and the high-producing strain (JCL260 ∆lysA pSA69). JCL16
colonies appeared later and ultimately formed flatter, more translucent mixed colonies that
Figure 3.1: 2-ketoisovalerate screening implementation on agar plates. (A) Mixture of JCL16 ∆lysA
and JCL260 ∆lysA pSA69 mixed colonies after 6 days at 37 oC. More opaque white colonies contain
JCL260 ∆lysA pSA69, while more translucent colonies are JCL16 ∆lysA. Scale bar represents 0.5
cm. (B) Composition of colonies after 7 days incubation at 35 oC. Error bars represent the standard
deviations of 4 colony replicates, with 4 technical replicates each. (C) Colony area over time for the
plates. Growth curves are shown from 55 colonies on a JCL260 ∆lysA alsS plate and 48 colonies on
a JCL260 ∆lysA pSA69 plate. The inset shows a histogram of colony appearance times, combined
from three plates of each secretor strain (126 total colonies from JCL260 ∆lysA pSA69 plates and
110 colonies from JCL260 ∆lysA alsS plates).
are easily distinguishable from the taller, opaque JCL260 ∆lysA pSA69 mixed colonies, even
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once both have grown to a substantial footprint area (Fig. 3.1A). Higher-production-level
secretors also produced colonies with increased sensor-to-secretor ratio (Fig. 3.1B). When
the composition of the mixed colonies on plates with norvaline was assessed, it was found
that on 0.5 g/L norvaline, JCL16 ∆lysA produced colonies that were majority secretor, while
JCL260 ∆lysA alsS and JCL260 ∆lysA pSA69 produced ones that were majority sensor. On
1.0 g/L norvaline, both JCL16 ∆lysA and JCL260 ∆lysA alsS produced colonies that were
mainly secretor cells, while JCL260 ∆lysA pSA69 still produced colonies that were majority
sensor. We next compared the growth of the intermediate level strain (JCL260 ∆lysA alsS )
and the high production strain (JCL260 ∆lysA pSA69). Here, both strains eventually formed
large opaque colonies, but JCL260 ∆lysA alsS colonies appeared later. We implemented the
ScanLag technique for automated imaging and colony growth profile analysis developed by
Levin-Reisman et al. [93,94], to observe colony lag time and growth dynamics. This inexpen-
sive method uses photo scanners to image the Petri dishes periodically during growth and
a MATLAB-based application that aligns the images and returns colony growth phenotype
information. The analysis revealed that JCL260 ∆lysA alsS mixed colonies appear later and
then grow to eventually reach similar colony size as JCL260 ∆lysA pSA69 mixed colonies
(Fig. 3.1C).
For the tryptophan system, we compared the ∆trpR strain and the base strain in the
agar plate-screening assay. Similar to the microplate, colonies were slow to develop on plates
that were not supplemented with any amino acids, but after two weeks we observed colonies
on the ∆trpR secretor co-culture plates and none on the base secretor co-culture plates, and
none on any monoculture plates. Addition of small initial amounts of histidine produced a
significant decrease in time required for colony visibility while maintaining clear differences in
the growth characteristics between the two secretor strains (Fig. 3.3A, B). In this case, both
the base and improved secretor strains formed colonies, but the base strain colonies were
flat, translucent, and easily distinguishable from the taller, opaque ∆trpR secretor colonies.
For the 2-KIV, we tested the addition of norvaline to the agar plates and found that it
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Figure 3.2: Population composition determination of mixed colonies by plating dilutions of the
colony on LB plates with IPTG/X-gal. Blue colonies are sensor cells; white colonies are secretor
cells. Spots from serially diluted colonies from plates with no (A), 0.5 g/L (B) and 1.0 g/L (C)
norvaline are shown. Spots of the dilutions were also plated on LB plates with tetracycline to
determine secretor strain CFU concentration compared to total CFU concentration.
was also effective in this format in widening the difference in growth between co-cultures con-
taining the intermediate- and high-producing secretor strains (Fig. 3.4). At 0.5 g/L norva-
line, only the highest producing strain (JCL260 ∆lysA pSA69) formed opaque colonies, while
the intermediate-producer (JCL260 ∆lysA alsS ) developed smaller, translucent colonies that
were not visible in the scanner images.
We also tested the push-pull arrangement on agar plates. We observed similar trends
to those in the microplate, with the mixed colonies appearing later for secretor strains with
higher Kdc/Adh expression levels (3.5D, E).
3.2.2 Screening model libraries in the agar plate format
To evaluate the ability of the agar plate screening assay to identify rare higher-producing
strains, we tested model libraries consisting of the intermediate-producing strain spiked with
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Figure 3.3: Tryptophan screening implementation on agar plates. Images after 72 h incubation (A)
and colony growth profiles (B) of agar plate co-cultures comparing secretor strains K12 ∆hisD and
K12 ∆hisD ∆trpR, with 5 µM initial histidine.
a small percentage of the high-producing strain. On each plate, we observed the development
of many small translucent colonies as well as a smaller number of large opaque colonies. We
isolated the secretor from the large colonies and investigated the strain identity.
In one experiment, we spread a square 24.5 cm plate with 102 ± 25 LB-CFU of JCL260
pSA69 and 18,200 ± 500 of JCL260 ∆lysA alsS (based on plating the inocula on LB plates;
SD, n = 2). This amounts to a library consisting of 0.6% high secretor, 99% medium secretor
strain. After 7 days, 25 large colonies were apparent and are numbered in yellow in Fig. S5.
17 intermediate-sized colonies were also observed. The four that were further investigated
are numbered in blue (Fig. 3.6)A).
Numbered colonies, as well as 4 small colonies, were streaked on LB plates with tetracy-
cline and kanamycin to isolate secretor strain. A single colony from each of these plates was
assayed by PCR using primer sets alsS int chk front for/alsS int chk front rev, which pro-
duce a short band only if alsS is integrated, and alsS int chk front for/alsS int chk back rev,
which produce a short band only if alsS is not integrated (Fig. 3.6D). 24 of the 25 large
colonies were identified as JCL260 ∆lysA pSA69. Colony 13, the only large colony which
was identified as containing JCL260 ∆lysA alsS, was a particularly large colony, so we sus-
pected it could have merged with surrounding small colonies, leading to a mixture of secretor
strains. We repeated the streak out of Colony 13 on an LB tetracycline plate, picking cells
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Figure 3.4: Norvaline addition to agar plates for 2-KIV screening. Agar plate co-cultures containing
various concentrations of norvaline, after 168 h incubation at 35 oC. At 0.5 g/L norvaline, JCL260
∆lysA alsS plate has no visible colonies.
from the very center of the colony. When we repeated the PCR assay on 10 colonies from
this streak, we found that 9 of 10 were JCL260 ∆lysA pSA69 and only one was JCL260
∆lysA alsS.
The four small colonies that were chosen were all identified as JCL260 ∆lysA alsS, as
expected. Of the four intermediate-sized colonies that were investigated, three were JCL260
∆lysA pSA69 and one (colony 30) was JCL260 ∆lysA alsS. Colony 30 is quite close to
colony 6, so it is possible that diffusion between colonies in close proximity is occurring,
which should be taken into consideration when selecting colonies.
A 0.1% model library was also tested. We plated 9.1 ± 1.6 LB-CFU of JCL260 ∆lysA
pSA69 and 78,500 ± 70 LB-CFU (SD, n = 2) of JCL260 ∆lysA alsS on each of two square
plates. After six days incubation at 37 oC, one plate had developed one large colony and the
other developed two. All three large colonies were found to contain JCL260 ∆lysA pSA69
as the secretor strain.
We concluded that, when an appropriate level of norvaline is utilized for the range of
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Figure 3.5: Push-pull screening in agar plate format. Colony growth profiles (A) and colony
appearance time histogram (B) for agar plate assay comparing the four secretor strains. Plot in
(A) shows profiles for the unmerged colonies from one plate of each secretor strain (29, 50, 34, 84 for
JCL260 ∆lysA pSA69, JCL260 ∆lysA cm 20 pSA69, JCL260 ∆lysA cm 80 pSA69, JCL260 ∆lysA
pSA65/9, respectively) (the JCL260 ∆lysA pSA65/9 plates have more unmerged colonies because
colony size is smaller). The histogram in (B) shows appearance times for the unmerged colonies
from a combination of two plates from each strain except for JCL260 ∆lysA pSA65/69 for which
colonies from one plate are included since smaller colony size resulted in reduced merging and more
analyzable colonies per plate. In total, this amounts to 85 from JCL260 ∆lysA pSA69, 119 from
JCL260 ∆lysA cm 20, 89 from JCL260 ∆lysA cm 80, and 84 from JCL260 ∆lysA pSA65/9. (C)
Plate images after 144 h incubation. Legend in (A) also applies to (B) and (C).
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Figure 3.6: Model library on an agar plate. (A) 0.6% library plate after incubation at 37 oC for
7 days, imaged from below on photo scanner. Colonies that were further examined are numbered.
(B) A close-up of the plate, photographed from above. Many small colonies are visible surrounding
the large colonies. (C) Production levels of secretor strain isolated from colonies 1 and 3 in the
screen after transformation with pSA65, in comparison with JCL260 ∆lysA pSA65/9 and JCL260
∆lysA alsS pSA65. Error bars represent standard deviation between two biological replicates. (D)
Verification that large colonies in the model library are JCL260 ∆lysA pSA69 and not JCL260
∆lysA alsS. Gel electrophoresis of PCR reactions with either primers alsS int chk front for and
alsS int chk front rev (top) or alsS int chk front for and alsS int chk back rev (bottom). M is In-
vitrogen 1 Kb plus ladder, C1 is JCL260 ∆lysA pSA69, C2 is JCL260 ∆lysA alsS. 1-25 are secretor
strain colonies isolated from the 25 largest mixed colonies. 26-29 are secretor strain isolated from
four small colonies from the model library plate. 30-33 are intermediate-sized colonies. Numbers
correspond to the numbering shown on (A), except for the small colonies which are not visible in
that image.
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strain improvement that is targeted, the screening can easily identify rare higher production
level strains at frequencies as low as 0.1% (or lower if a larger number of plates are employed).
Transformation with pSA65 and production testing of secretor cells isolated from the colonies
confirmed that the strain is not adversely affected by the screening conditions (Fig. 3.6C).
3.2.3 Screening of a chemically-mutagenized strain library for improved plasmid-
free isobutanol production
We next applied the SnoCAP screening method to strain development for higher 2-KIV
production based on genomic modifications (rather than by pathway overexpression from
the pSA69 plasmid). We introduced random mutations into the genome of JCL260 ∆lysA
alsS by mutagenesis with N-Methyl-N’-nitro-N-nitrosoguanidine (NTG). NTG is a chemical
mutagen that adds alkyl groups to the O6 of guanines and, to a lesser extent, the O4 of
thymines, leading to mispairing during DNA replication and thus mutations. We plated the
library on 24.5 cm square Petri dishes containing various concentrations of norvaline, along
with an excess of sensor strain. 104 LB-CFU (cells that would form colonies in monoculture
on an LB plate) of secretor strain library were spread on each plate. After seven days of
incubation at 37 oC, we identified large opaque colonies among the large number of small
translucent colonies. We streaked large colonies from the 1.0 g/L norvaline condition on LB
plates with tetracycline to select for the secretor strains and then rescreened them in the
microplate co-culture assay and selected 7 isolates that showed improved co-culture growth.
We transformed these isolates with pSA65 and tested their isobutanol production. Due to
reduced growth rates observed in some of the library isolates, we tested their production
levels in M9IPG supplemented with 5 g/L yeast extract. Of the 7 isolates tested, one,
which we call strain B1, showed significantly improved production compared to the base
strain. After 73 h fermentation, B1 pSA65 produces 9.4 ± 0.4 g/L (SD, n = 3) isobutanol,
representing 60% of the theoretical yield, compared to 1.8 ± 0.1 g/L and 16% theoretical
yield by the parental strain JCL260 ∆lysA alsS (Fig. 3.7). It should be noted that JCL260
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∆lysA alsS performs less well under yeast extract supplemented conditions compared to
minimal medium conditions, likely due to lower expression of the ilvCD genes when it is not
necessary to produce all of its own amino acids. Nevertheless, B1 isolate performs superiorly
even to JCL260 ∆lysA alsS ’s production level in minimal medium (i.e., the production level
presented in Fig. 2.2B). B1 performs nearly as well as JCL260 ∆lysA pSA69, but through
a different mechanism than plasmid overexpression of the ilvCD genes.
Figure 3.7: Production culture performance of mutagenesis library isolate B1 compared to parent
strain JCL260 ∆lysA alsS and high-producing strain JCL260 ∆lysA pSA69. Error bars represent
standard deviations of biological replicates (n = 3).
To investigate the mutations leading to this improved production, we sequenced the
genome of B1 and parental strain with >100X coverage and identified 73 SNPs, 39 of which
lead to amino acid substitutions or stop codon introductions, in B1. The latter set of
mutations are listed in Table 3.1. Interestingly, most of the mutations in this strain are
clustered in the 3.1-3.3 Mb and 3.8-4.6 Mb regions. There is a strong bias for G/C to A/T
transitions, as has been previously reported for NTG-mutagenesis in E. coli (e.g., [95]).
One intriguing mutation occurs in the aceK gene, which encodes the isocitrate dehy-
drogenase kinase/phosphatase. This bifunctional enzyme controls the branch between the
tricarboxylic acid (TCA) cycle and glyoxylate cycle by modification of isocitrate dehydroge-
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nase. B1’s mutation consists of a proline to serine substitution in residue 510, which is part
of the substrate recognition loop [96]. We reintroduced this mutation into a mutS- version of
the parental strain by single-stranded oligo recombination, calling this strain JCL260 ∆lysA
alsS aceK-mut. When tested in liquid co-culture with the sensor strain, JCL260 ∆lysA alsS
aceK-mut shows improved co-growth compared to the parental strain (Fig. 3.8A). After
transformation with pSA65, we compared the production and found that this mutation does,
indeed, lead to a modest increase in isobutanol production (Fig. 3.8B).
Figure 3.8: aceK mutant strain characterization. (A) Growth profiles of secretor strains co-cultured
with K12 ilvD sensor strain in a 96-well microplate with 0.1 g/L norvaline (n = 4, replicates plotted
in the same color). (B) Monoculture isobutanol production and growth profiles of aceK mutant
strain and parental strain after transformation with pSA65. Error bars represent the standard
deviation of biological replicates (n = 10). For isobutanol production at the 24 hr time point,
two-tailed P-value < 0.0001.
AceK activity is required for growth on acetate [97]. We found that both B1 and
JCL260 ∆lysA alsS aceK-mut were able to grow in an M9 medium with 20 g/L acetate
as the sole carbon source (supplemented with lysine), which indicates that the mutation
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does not completely abolish AceK activity. Knockout of aceK has previously been used to
increase L-carnitine production [98].
Another mutation of potential interest occurs in the ilvC gene (part of the isobutanol
pathway): a glycine to aspartate mutation at amino acid position 442. Although this is an
unstructured region of the protein, it may still merit further investigation since the gene is
part of the production pathway.
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Table 3.1: SNP mutations identified in the genome of strain B1, which was derived by random
mutagenesis and SnoCAP screening and has improved 2-KIV/isobutanol production
Mutation
coordinate in
BW25113 [99]
Nucleotide
substitution
Gene Gene annotation Amino acid
substitution
284584 C→T xynR CP4-6 prophage; DNA-binding transcriptional
repressor XynR
G97E
1014968 C→T ompA outer membrane porin A G181D
1101625 C→T ymdB 2’-O-acetyl-ADP-ribose deacetylase, regulator of
RNase III activity
A117V
2349193 C→T glpC anaerobic glycerol-3-phosphate dehydrogenase
subunit C
A65V
3118229 C→T glcF glycolate dehydrogenase, putative iron-sulfur subunit G197E
3119643 C→T glcE glycolate dehydrogenase, putative FAD-binding
subunit
S80N
3158414 C→T parC dimer of DNA topoisomerase IV subunit A D307N
3202308 C→T ttdT L-tartrate:succinate antiporter A309V
3203862 C→T tsaD N6-L-threonylcarbamoyladenine synthase, TsaD
subunit
G14D
3247697 C→T yhaK bicupin-related protein A7V
3250346 C→T cyuP putative D/L-serine transporter A342T
3252440 C→T tdcG L-serine deaminase III G190D
3256586 C→T tdcD propionate kinase S145N
3264955 C→T garK glycerate 2-kinase 1 A59T
3830769 C→T setC putative arabinose exporter L153F
3837065 C→T adeQ adenine transporter V29I
3952654 G→A ilvC ketol-acid reductoisomerase (NADP+) G442D
3952951 T→C ppiC peptidyl-prolyl cis-trans isomerase C T75A
3963542 C→T wecB UDP-N-acetylglucosamine 2-epimerase A17V
3988970 G→A yigA conserved protein YigA E10K
3992126 G→A uvrD ssDNA translocase and dsDNA helicase - DNA
helicase II
E262K
4026380 C→T yigZ IMPACT family member YigZ L177F
4132894 C→T frwC putative PTS enzyme IIC component FrwC T146I
4195232 C→T purD phosphoribosylamine—glycine ligase A210T
4210051 C→T aceK isocitrate dehydrogenase kinase / isocitrate
dehydrogenase phosphatase
P510S
4245002 C→T plsB glycerol-3-phosphate 1-O-acyltransferase G465S
4264125 C→T ssb ssDNA-binding protein P25S
4269416 C→T ghxP guanine/hypoxanthine transporter GhxP A337V
4313755 C→T phnD phosphonate ABC transporter periplasmic binding
protein
A139T
4333393 C→T melB melibiose:H+/Na+/Li+ symporter R70STOP
4334603 C→T melB melibiose:H+/Na+/Li+ symporter A474Va
4338165 C→T dcuB anaerobic C4-dicarboxylate transporter DcuB A133T
4382187 C→T glyY tRNA-Gly(GCC)
4388964 C→T mutL DNA mismatch repair protein MutL T579I
4430279 C→T ytfL putative inner membrane protein D252N
4515057 C→T yjhI KpLE2 phage-like element; putative DNA-binding
transcriptional regulator YjhI
W188STOP
4545803 C→T yjiC uncharacterized protein YjiC G112D
4556915 C→T yjiN DUF445 domain-containing protein YjiN G50D
4565276 C→T yjiV putative uncharacterized protein YjiV S442F
4587974 C→T opgB phosphoglycerol transferase I A429T
4627746 C→T creC sensory histidine kinase CreC P412S
aThis mutation is downstream of the introduced stop codon
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3.2.4 Microdroplet co-cultivation and sorting implementation
To further increase the throughput of the SnoCAP screening framework, we next inves-
tigated compartmentalization by encapsulation in microfluidic water-in-oil droplets. These
monodisperse droplets, with volumes in the picoliter to nanoliter range, provide miniatur-
ized culture volumes that can be analyzed in a variety of ways, including by high-throughput
automated sorting to isolate droplets containing the highest fluorescence signal. Cells are
distributed according to a Poisson distribution, and cell density can be manipulated to en-
sure that initially i) all droplets contain several sensor cells, and ii) the majority of droplets
contain either zero or one secretor cell.
To couple the co-growth output to fluorescence, we expressed fluorescent proteins in
the strains. We first labeled the high secretor, JCL260 ∆lysA pSA69, with YFP, the sensor
strain with mCherry, and observed co-culture growth in droplets (Fig. 3.9A). For sorting, we
employed a version of the sensor strain carrying a plasmid encoding constitutively expressed
mNeonGreen and screened by FADS for droplets with the highest fluorescence, corresponding
to the largest number of sensor cells.
We observed that the sensor strain cells tend to become very long (sometimes >50 µm
in length), while the high-secretor cells generally remain a normal length. This may be due
to sensitivity to norvaline. At high norvaline concentrations we also sometimes observed
what appeared to be physical associations between the cells (Fig. 3.10). We hypothesize
this could be cross-feeding by intercellular nanotubes, as in [72]. Pande et al. found that
this type of cross-feeding led to an exchange of fluorescent proteins between the two types of
cells, so there is a possibility that that could be occurring in our system, although when both
cells were differentially labeled we visually observed individual cells to show only one type
of fluorescence strongly. This type of cross-feeding would allow more direct transfer of the
cross-feed metabolites, possibly allowing better tolerance of the norvaline. These lengthened
cells and physical associations were more prevalent when the medium was not freshly made
the day of the experiment.
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Figure 3.9: Screening for 2-KIV production implemented in microfluidic droplets. (A) Represen-
tative droplet images during co-growth of sensor strain expressing mCherry and JCL260 ∆lysA
pSA69 expressing YFP on 1.0 g/L norvaline. Each image is an overlay of fluorescence and bright-
field images, but cell locations do not align exactly due to cell movement between images. (B)
Droplet reinjection and spacing. (C, D) Fluorescence-activated droplet sorting (FADS) to retrieve
droplets with high levels of sensor strain growth. (E) Histograms comparing fluorescence signal
from droplets containing co-cultures with different secretor strains (at an initial cell loading of
0.2 secretor and 5 sensor/droplet) on several concentrations of norvaline after a 30 h incubation.
∼50,000 droplets under each condition were analyzed. Scale bars: (A) 50 µm, (B-D) 100 µm.
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Figure 3.10: Droplet of diameter∼55 µm containing medium with 1.5 g/L norvaline and a co-culture
of K12 ∆ilvD pSAS31 sensor strain and unlabeled JCL260 ∆lysA pSA69 high-level secretor. In
this droplet, the cells appear to physically associate. Image shows green fluorescence, which is
indicative of the sensor cell. Variation in cell length and fluorescence intensity is visible between
cells. Scale bar: 10 µm
We tested the ability of FADS to distinguish between two strains of differing production
levels and to isolate the high secretor, JCL260 ∆lysA pSA69, when spiked at low percentages
into a population of lower secretor cells. We identified conditions (i.e., an appropriate nor-
valine concentration) that enabled the desired level of separation between the two strains,
encapsulated model libraries consisting of mixtures of the two secretor strains, incubated
to allow co-growth with the sensor strain within the droplets, and then sorted to isolate
the most fluorescent droplets. In order to monitor the collective growth in the droplets and
determine what stage of growth most droplets are in, we incubated ∼100 µL of droplets in a
microplate, incubated it in a microplate reader set to measure fluorescence every 15-20 min.
We compared fluorescence of droplets incubating in 1.5 mL Eppendorf tubes compared to
those incubating in the microplate reader and found that they were comparable (Fig 3.11).
The cell suspension for encapsulation was prepared so that one would expect an average of
0.1 secretor cell/droplet if droplets were 50 µm in diameter and the same cell suspension was
used for the three different droplet sizes, which may explain why the smaller droplets reach
a lower total fluorescence than the larger droplets.
We mixed JCL260 ∆lysA pSA69 and JCL260 ∆lysA alsS galK::cat (galK deletion
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Figure 3.11: Collective droplet fluorescence profiles over time. Fluorescence readings in a microplate
reader of droplets of various sizes, either incubated within the reader, taking measurements every
20 min or incubated in a 1.5 mL Eppendorf tube and transferred into a microplate for readings.
enabled color-based differentiation of the strains when plated on MacConkey agar with
galactose, Fig. 3.12B) at a ratio of 1:100 and encapsulated them with sensor strain K12
∆ilvD::kan pSAS31 on 1.75 g/L norvaline. We used cell densities such that the secretor
cell loading was ∼0.1/droplet (cells are encapsulated according to Poisson distribution, with
∼90% containing no secretor) and sensor cell loading of ∼5/droplet. Following incubation to
allow co-culture growth, the droplets were reinjected into a sorting device (Fig. 3.9B) and
sorted based on fluorescence from excitation with a 450 nm laser (Fig. 3.9C,D). We selected
sorting gate values based on comparisons of the signal profiles from mono-secretor control
sets of droplets (Fig. 3.9E) and verified their effectiveness by observing that these values
enabled bright droplets to be collected. For application to a library when a high-producing
strain is not already available, the threshold can be selected to sort the top percentage of
droplets at a desired stringency. After sorting, desired droplets were collected into a poly-
dimethylsiloxane (PDMS) device with an elevated chamber to retain droplets while allowing
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Figure 3.12: Retrieval of viable cells after droplet sorting. (A) Droplets collected after 25 min
sorting of droplets encapsulating a mixture of JCL260 ∆lysA alsS and JCL260 ∆lysA pSA69
secretor strains at a 100:1 ratio. Scale bar: 100 µm. (B) Strain growth on MacConkey agar plates
containing tetracycline. K12 ∆ilvD pSAS31 (1) does not grow. JCL260 ∆lysA alsS galK::cat (2)
produces white colonies, and JCL260 ∆lysA pSA69 (3) produces purple colonies. (C) Colonies
from plating unsorted droplets. (D) Colonies from plating the collected droplets that are pictured
in (A).
oil to flow out. In a 25 min sorting period, we isolated 10 droplets, each of which showed
significant sensor cell growth. Plating these droplets on a MacConkey agar plate with tetra-
cycline (to prevent growth of the sensor strain) produced only purple colonies (>100-fold
enrichment of the high-secretor) (Fig. 3.12D), whereas plating the unsorted droplets pro-
duced a mixture with 16% purple colonies (16-fold enrichment) (Fig. 3.12C). We assessed
the productivity of purple colonies that resulted from sorted droplets after transformation
with pSA65 and found that they maintained their productivity through the screening process
(Fig. 3.13).
We noticed lower than expected cell recovery from the collected droplets. We also
observed that the collected droplets begin to shrink after the collection device is disconnected
from the sorting device and that shrinkage is less severe when larger numbers of droplets are
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Figure 3.13: Productivity after retrieval from droplets. Isobutanol production of cells from eight
randomly selected purple colonies isolated from sorting of model libraries and transformed with
pSA65, compared to JCL260 ∆lysA alsS pSA65 and JCL260 ∆lysA pSA65/9. Error bars represent
standard deviation of two biological replicates.
collected. We assessed whether viability is affected by the sorting process itself by running
cell-containing droplets through the device either into the waste channel (electrode turned
off) or into the collection channel (electrode turned on), collecting the droplets in Eppendorf
tubes and assessing the cell viability. We found no significant difference between the droplets
that had not been reinjected, the waste channel droplets, and the positive channel droplets
(1.7x104 ± 3.4x103, 2.0x104 ± 3.2x103, and 1.6x104 ± 88 CFU/µL droplets (SD, n = 2),
respectively). We, therefore, conclude that droplet shrinkage is likely to cause incomplete
cell recovery. Subsequently, as an alternative and direct way of examining sorting efficiency,
we labeled the high secretor JCL260 ∆lysA pSA69 with mCherry by transformation with
ampicillin-resistant pBT-proD-mCherry. To enable cultivation in ampicillin, lower secretor
JCL16 ∆lysA was transformed with empty pTGD plasmid and K12 ∆ilvD ∆galK::cfp-bla
pSAS31 (expressing both CFP and mNeongreen) was employed as the sensor strain. Thus,
droplets could be sorted for green fluorescence and accuracy could be assessed based on
whether droplets contained mCherry-expressing cells.
We encapsulated a mixture of JCL260 ∆lysA pSA69 and JCL16 ∆lysA at a 1:1,000
ratio on 1.0 g/L norvaline. In 30 min of sorting at a droplet reinjection rate of 2 µL/min
(∼400,000 droplets total, or ∼40,000 containing a secretor strain), we retrieved five droplets
in the collection device. All five contained substantial numbers of green fluorescent cells,
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Figure 3.14: Droplets before and after fluorescence-activated droplet sorting (FADS). (A) ∼90 pL
droplets were generated containing sensor strain at a cell loading of ∼5 sensor cells/droplet and
secretor strains JCL16 ∆lysA pTGD and JCL260 ∆lysA pSA69/pBT1-proD-mCherry, mixed at a
ratio of 1,000:1, with a total loading of ∼0.1 secretor cell/droplet. After 36 h incubation, a sample of
these droplets was examined. One droplet with substantial sensor cell growth is visible from among
∼5*104 droplets (A, B). This droplet was identified as containing JCL260 ∆lysA pSA69/pBT1-
proD-mCherry secretor strain by observation of cells expressing mCherry (C). After 30 min FADS
of these droplets, five droplets were collected (D-F). All five showed growth of the sensor strain
as determined by cells with green fluorescence (E) and four contained cells with red fluorescence,
indicative of JCL260 ∆lysA pSA69/pBT1-proD-mCherry (F). Scale bars: (A) 500 µm, (B-F) 100
µm.
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while four contained red fluorescent cells, indicative of the high secretor (true positive) (Fig.
3.12). This demonstrates the accuracy of the sorting system at high throughput (i.e., it is
possible to sort a large number of droplets and isolate only those containing a high number
of green cells) and the low biological false positive rate.
Figure 3.15: Droplets in droplet spacing device. The leftmost droplet displays significant growth.
We were also interested in whether we can isolate and retrieve cells from individual
droplets. Each droplet will contain a single genotype of secretor, so it will be most efficient
to isolate individual droplet after sorting and evaluate the cells from each one, as opposed
to pooling the droplets and picking colonies that may have come from the same droplet.
For this purpose, we utilized the droplet spacing device of [100]. This device incorporates
a valve that, when partially closed, prevents droplets from flowing out of the device. It can
be used to dispense individual droplets into wells of a microtiter plate. We encapsulated
a mixture of JCL260 ∆lysA alsS ∆galK and JCL260 ∆lysA pSA69 in 125 µm diameter
droplets and incubated to allow growth. We performed this experiment prior to optimizing
the growth conditions, so not all of the encapsulated cells grew. Nevertheless, we identified
some droplets with significant growth, such as the leftmost droplet in Fig. 3.15. Note that
the droplets with significant cell growth are smaller than droplets without growth. This is
likely due to osmosis occurring because of sugar consumption [101]. We used the spacing
device to isolate six of the droplets that displayed good cell growth, depositing them into
wells of a 96-well microplate. When these droplets were chemically destabilized and plated
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on LB plates with tetracycline (to prevent growth of the sensor strain), four droplets yielded
colonies and two droplets produced no colonies. The four that did produce colonies had 2,
13, 18, and 36 colonies, respectively. All colonies were purple, indicating they were JCL260
∆lysA pSA69. Several colonies from each plate were also assayed by PCR to verify that
they were indeed the high secretor strain. This technique can potentially be employed on
the pools of droplets collected by FADS to isolate single droplets and reduce the amount of
rescreening required. However, the spacing device is challenging to operate and it is easy to
lose droplets, so it would be best to optimize the collection efficiency further or use when a
large pool of droplet has been collected so that loss of droplets is not a problem.
3.3 Discussion and conclusion
We have demonstrated the implementation of SnoCAP as both a colony screening assay
and utilized it to identify an efficient isobutanol production strain from a chemical mutage-
nesis library. We have also implemented the screening in microdroplets and demonstrated
its ability to identify rare high-producers by testing model libraries. Each implementation
formats has its own advantages and limitations. The microtiter plate assay of Chapter 1,
although requiring the most space, avoids the issue of single cell variability and therefore
provides the highest accuracy, with the tightest agreement of replicates, both between and
within experiments. The agar plate format reaches high throughputs (up to ∼105 assays
per square meter of plate surface) and does not require specialized equipment. The high cell
density possible in a colony enables a large number of doublings and hence a large degree of
amplification of differences in production phenotype. The microdroplet format achieves ul-
trahigh throughputs (∼106 droplets/h, corresponding to ∼105 assays/h, or ∼106 assays/day,
when a secretor loading of ∼0.1/droplet is used) that can drastically reduce screening time
and enable screening of libraries that are orders of magnitude larger. The small culture
volume also significantly shortens the requisite incubation periods.
The droplet format can provide substantial time and cost savings. Agresti et al. [102]
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estimate that to perform 5*107 assays in microplates with liquid-handling robots would
require two years and $10 million in pipette tip costs alone. At the sorting rates reported
here, it would take about three weeks to evaluate 5*107 assays and further optimization of
the assay can lead to reductions in this time. The cost is also quite low, with the major cost
being the optical setup (∼$10,000). Amortized over five years, this amounts to an equipment
cost of $100 for a three week screening endeavor.
As with most high-throughput single cell tools, single cell variability decreases the
precision of the agar plate and microdroplet formats. In the microdroplet assay, there is
additional variability between replicates because the cells are encapsulated according to the
Poisson distribution, and each droplet does not start with an identical number of sensor cells.
One-to-one pairing of the cells (using techniques such as those presented in [103] or [104])
could be explored to achieve a more uniform sensor cell number per droplet. A more sophis-
ticated incubation setup for improved aeration (such as that presented in [105]) may also
improve the homogeneity of the conditions experienced by each droplet. The microdroplet
sorting assay could also be further developed to enable even higher throughputs and to screen
based on different sorting criteria. We have screened by sensor strain content, but secretor-
to-sensor ratio may also be a useful quantity to examine. Advances in absorbance-activated
droplet sorting (such as that reported in [106]) may also enable application to screening
strains that are not easily made fluorescent.
An interesting future application of these high-throughput forms of SnoCAP would be
to take an inverse metabolic engineering (IME) approach, reintroduce the B1 mutations by
multiplex automated genome engineering (MAGE) or by cloning genomic fragments into a
plasmid, and rescreen this library to elucidate the mechanism of production improvement.
For certain applications, the microdroplet assay could also be combined with next-generation
sequencing in order to gather large amounts of data about which members of a library
perform well or poorly. For example, a ribosome binding site or promoter library could be
generated and the results compared between cells from droplets that are positively sorted
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and those that are negatively sorted.
3.4 Materials and methods
3.4.1 Strains and plasmids
Strains and plasmids used that were not already listed in Tables 2.1 and 2.2 are listed
in Tables 3.2 and 3.3. pET-ara-mCherry was constructed by Jihyang Park [46] and pSAS31
by Scott Scholz [107]. The ∆intC::yfp-cat construct was initially obtained from the DS1-Y
strain, from the Balaban group, Hebrew University of Israel. pBT1-proD-mCherry was a
gift from Michael Lynch (Addgene plasmid #65823).
3.4.2 Gene deletions, insertions and modifications
Oligonucleotides are listed in Table 3.4.
To introduce the aceK gene mutation into JCL260 ∆lysA alsS, we first knocked
out the mutS gene using single-stranded -Red recombineering using pSIM5 [84] and oligo
mutS STOP JM to introduce premature stop codons. We then used single-stranded λ-Red
recombineering with oligo aceK 510 mut oligo to introduce the SNP into aceK. Both mutS
and aceK were verified by allele-specific PCR and Sanger sequencing by the University of
Michigan Sequencing Core (Ann Arbor, MI).
To knock out the galK gene, we amplified the cat gene from NV3r1 cm 20 gDNA using
primers galK cat for and galK cat rev to add homology to the galK locus. The resulting
linear construct was integrated by λ-Red recombineering with pSIM6 [84] into JCL260 ∆lysA
alsS.
For fluorescent labeling of cells, K12 ∆ilvD ::FRT was transformed with either pET-ara-
mCherry or pSAS31. Secretor strains JCL260 ∆lysA::FRT alsS and JCL260 ∆lysA::FRT
pSA69 were P1 transduced with ∆intC::yfp-cat P1 lysate in order to integrate the yfp gene
into the intC locus.
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3.4.3 Cell preparation for cross-feeding screening
For the agar plate assay, cells were prepared in the same manner as for the microtiter
plate assay. For the droplet assay, the stationary phase cultures were subcultured in 10
mL culture volumes into exponential phase (∼3.5 h for JCL260-based strains and ∼2 h for
K12-based strains). The cells were harvested by centrifugation at 5,000 g for 5 min, washed
twice in 1x M9 salts, and resuspended in the culturing medium (M9IPG with norvaline at
the specified concentration). Cell density was then determined based on an OD600 to CFU
calibration. Cell inocula were kept at room temperature and each culture was combined just
before droplet generation. Each inoculum culture was serially diluted and spot plated on
LB plates with kanamycin to verify CFU concentration. After completing the experiments
presented in this chapter, we determined that using stationary phase cells for the droplet
assay is also effective and may provide better consistency in growth performance.
3.4.4 Agar plate assay
Setup Plates were either 10 cm round Petri dishes, or 24.5 cm square bioassay dishes.
M9IPG with 5 g/L glucose, 3 mM isoleucine, 12 g/L agar, 0.1 mM IPTG and 50 µg/mL
kanamycin was used for all plates in the 2-KIV screen. M9IPG with 4 g/L glucose, 12 g/L
agar and no antibiotics was used for all microplates in the tryptophan screen. The prepared
sensor cells were diluted 10-1, secretor cells were serially diluted to the desired concentrations.
On round plates, 100 µL of 10-1 diluted sensor cells and 200 µL 10-6 diluted secretor cells
were spread with glass beads. On square plates, 1 mL of 10-1 diluted sensor cells and a
combination of secretor cells totaling ∼104 CFU were spread with glass beads. Plates were
allowed to dry thoroughly before incubation to ensure good separation of colonies. 10-6
dilutions of secretor strains were also plated on LB plates to determine LB-CFU counts.
The LB-CFU counts were used to determine model library percentages.
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Plate scanning and analysis Automated scanning and ScanLag analysis was performed
according to the method of [93, 94], using Epson Perfection V37 photo scanners. Custom
holders were 3D-printed so that plates would be located in consistent locations between
experiments. Plates were covered with sterile black felt prior to incubation and scanning.
Scanners and plates were incubated at 35 oC to accommodate recommended scanner op-
erating temperature. Images were taken every 30 min. for the duration of the incubation
period. Following colony growth, images were aligned and colonies detected. Colonies that
had merged by the end of the culture period were eliminated from the growth profile plots.
Colony composition determination Entire colonies were scooped off plate using inoc-
ulation loops and resuspended in M9 salts. The colony suspension was then serially diluted
and plated in the same manner described for the microplate population composition deter-
mination.
Determination of strain identity Secretor strains were isolated from mixed colonies by
streaking on LB plates with tetracycline. The resulting colonies were then assayed by colony
PCR with primers alsS int chk front for and alsS int chk front rev, which produce a short
band if alsS is integrated, and with alsS int chk front for and alsS int chk back rev, which
produce a short band if alsS is not integrated.
NTG mutagenesis and mutant screening NTG mutagenesis was performed according
to the method of 10. The parental strain (JCL260 ∆lysA alsS ) was cultured overnight in
LB medium and then diluted 1% (v/v) into 5 mL of fresh LB and grown at 37 oC to an
OD600 of 0.5. Cells were pelleted by centrifugation at room temperature (5,000 rpm, 10 min)
and washed twice with an equal volume 0.1 M Na citrate (pH 5.5) before resuspension in
0.1 M Na citrate (half the original volume). NTG was added to a final concentration of
50 µg/mL from a 1 mg/mL stock in 0.1 M Na citrate and incubated at 37 oC for 15 min.
For the control experiment, an equal volume of 0.1 M Na citrate was added instead of NTG.
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After incubation, cells were washed twice with the original volume of 0.1 M phosphate buffer
(pH 7.1). The cells were then resuspended in 5 mL of LB and incubated at 37 oC overnight
for outgrowth. Before outgrowth, a small volume of cells were diluted and plated for both
the NTG-treated tube and the control tube on LB plates to determine the kill count for
the experiment before outgrowth. After outgrowth, cells were prepared for the agar plate
screening as described in Cell preparation for cross-feeding screening, and plated with sensor
strain on 24.5 cm square plates containing 0.5, 0.75 or 1.0 g/L norvaline, and incubated at
37 oC for 7 days. Cells were also plated on LB plates to determine LB-CFU. A volume of
secretor cells corresponding to ∼6*104 LB-CFU was plated on each square plate. The largest
colonies from the cross-feeding screening plates were streaked on LB plates with tetracycline
to isolate the secretor. Colonies from these plates were then re-screened in the microplate
format of the co-culture screening. The most promising strains from the re-screening were
transformed with pSA65 and subsequently tested for isobutanol production performance.
Genomic sequencing The genomes of parental strain JCL260 ∆lysA alsS and mutant
B1 strain were sequenced by the University of Michigan Sequencing Core (Ann Arbor,
MI) by Illumina HiSeq-4000 using 0.5% of a lane for each strain. Genomic DNA of the
strains was isolated using a Qiagen DNEasy Blood and Tissue kit. The libraries were
prepared by the core, with 250 nt insert size and reads were 150 nt paired-end reads.
SolexaQA++ (http://solexaqa.sourceforge.net/) was used to trim the reads. Reads were
mapped to the reference genome (JCL260 ∆lysA alsS ) using Bowtie 2 (http://bowtie-
bio.sourceforge.net/bowtie2/), and SNPs were compared using SAMtools
(http://samtools.sourceforge.net/).
3.4.5 Microdroplet assay
Microfluidic device fabrication Polydimethylsiloxane (PDMS) droplet generation and
detection/sorting devices were fabricated using standard soft lithography methods. Briefly,
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an SU-8 photoresist (MicroChem Corp.) master mold was first created on a Si wafer by
photolithography. For the detection/sorting device, multiple coating and exposure steps were
required to construct flow channels and optical fiber grooves with different heights (50 µm
and 80 µm, respectively). The wafer was silanized with vapor phase trichloro(1H,1H,2H,2H-
perfluorooctyl)silane (Sigma-Aldrich) and the PDMS precursor was poured onto the master
mold and cured at 65 C overnight. The cured PDMS was peeled off the Si wafer, punched to
form inlets/outlets, treated with oxygen plasma (Femto Scientific Inc.) for activation, and
finally bonded to a glass slide to seal the device. For the droplet generation device, a 1.2
mm biopsy punch was used for both inlets and the oulet. For the detection/sorting device,
a 1.2 mm punch was used for the droplet inlet, a 1.5 mm punch for the electrodes, and a
0.75 mm punch for the oil inlets and droplet outlets. The microelectrodes were created by
flowing low melting Bi/In/Pb/Sn alloy (247 Solder) into the microchannels at 150 oC. The
optical fiber (F-MCB-T-1FC, Newport Corp.) was manually embedded into the fiber groove.
The sealed flow channel was flushed with trichloro(1H,1H,2H,2H-perfluorooctyl)silane at a
concentration of 2% (v/v) in Novec HFE-7500 prior to use. For the collection device, a ∼1
mm PDMS membrane containing a channel of height 100 µm and width 1 mm was punched
with an 8 mm diameter hole and bonded to another PDMS slab. An inlet and outlet were
punched with a 0.75 mm punch and the PDMS was bonded to a glass slide.
Encapsulation and cultivation Cells were prepared as described above. Individual
strain inocula were kept at room temperature (storage on ice decreases viability for co-culture
growth) and were combined with each other immediately before each set of encapsulation.
The strains were combined with additional medium to achieve a total secretor cell loading
of λSecretor = 0.1 cell per droplet and sensor cell loading of λSensor = 5 cells per droplet for
55 µm diameter droplets, or µSensor = 15 cells per droplet for ∼125 µm diameter droplets.
M9IPG medium with 20 g/L glucose was supplemented with 50 µg/mL kanamycin, 0.1 mM
IPTG, and norvaline at the specified concentration. For this assay, it is important that the
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medium be freshly made on the day of the experiment, and the LB medium used for growing
the inoculum cultures should also be fresh. The inoculated cell culture and Novec HFE-7500
fluorinated oil (3M) with 2% (w/w) PEG-PFPE amphiphilic block copolymer surfactant
(Ran Biotechnologies, 008-FluoroSurfactant) were loaded into separate syringes (BD, 1 mL
and 5 mL, respectively) and injected with 23 gauge needles through PTFE tubing (0.022”
ID, Cole-Parmer) into a flow-focusing droplet generation device using syringe pumps (Kent
Scientific) with flow rates of 10 µL/min and 45 µL/min, respectively. With a device with
channel height of 50 µm and aqueous and oil channel widths of 25 µm, these flow rates pro-
duced droplets with diameter of ∼55 µm. The emulsion was collected in 1.5 mL Eppendorf
tubes in 10 min aliquots (∼150 µL of emulsion). Excess oil was removed, except for ∼100
µL, and the capped Eppendorf tubes were then incubated at 37 oC. Overall population-level
growth characteristics were monitored by incubating 100 µL of droplets with 50 µL addi-
tional fluorinated oil with surfactant in a black clear-bottom microplate (Greiner), sealed
with a Mylar plate sealer (Thermo Scientific), in a microplate reader (BioTek Synergy H1)
at 37 oC, reading fluorescence every 15 min (excitation 485 nm, emission 528 nm). Droplets
were incubated for between 30 and 40 h. An Olympus DP71 microscope was used to examine
the cell growth.
Droplet sorting Following off-chip incubation, droplets were poured into a capped syringe
(Global, 1 mL) and any remaining volume of the syringe was filled with fluorinated oil with
2% surfactant before inserting the syringe plunger. We reinjected the droplets into a droplet
sorting device with height 50 µm and main channel width 55 µm using a syringe pump
(KD Scientific). The syringe was connected to the sorting device via a 23-gauge needle and
0.022” ID PTFE tubing. Droplets of 55 µm diameter were reinjected into the sorting device
at 1.5-2.5 µL/min, corresponding to ∼150-300 droplets/sec. Spacing oil with surfactant was
also injected into the device by syringe pumps. Sorting was performed in a manner similar
to that of [104], with the major difference being that droplets were generated using a droplet
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generation device, incubated off-chip to allow cell growth, and then reinjected into a sorting
device. The flow channel structure of the detection/sorting device was designed such that the
negative signal droplets spontaneously enter the waste channel due to lower flow resistance,
which results from a larger width and shorter length of the channel. The positive channel
was designed to have a high enough resistance that smaller broken droplets (which may occur
during reinjection) would also flow into the negative channel.
Cell retrieval and identity determination Collected droplets were examined by mi-
croscopy in the collection device. The secretor identity was either determined directly by
fluorescence, or by retrieving the droplets and plating on MacConkey agar plates to identify
cell type by colony color. For determination by fluorescence, the droplets were inspected by
a Nikon Eclipse Ti-S microscope to detect sensor strain green fluorescence (excitation filter
470/40, emission filter 525/50) and red fluorescence from mCherry (excitation filter 560/55,
emission filter 675/67). A droplet containing cells displaying red fluorescence under these fil-
ters indicated the presence of the secretor strain JCL260 ∆lysA pSA69/pBT1-proD-mCherry
and was therefore considered a positive droplet. For determination by colony count, the pool
of collected droplets was retrieved by inverting the collection device and injecting HFE-7500
oil into the device to flow the droplets into an Eppendorf tube. The droplets were then
chemically destabilized with 1H,1H,2H,2H-perfluoro-1-octanol. LB medium was added and
the aqueous portion was plated on MacConkey agar plates containing tetracycline and 1%
galactose. Plates were incubated for 48 h at 37 oC. Sensor cells did not grow due to the
tetracycline. JCL260 ∆lysA alsS ∆galK produced white colonies and JCL260 ∆lysA pSA69
produced purple colonies. Purple colonies (indicating JCL260 ∆lysA pSA69) were restreaked
on MacConkey agar plates with tetracycline and kanamycin (growth verified maintenance of
the pSA69 plasmid) and on MacConkey agar plates with tetracycline and chloramphenicol
(lack of growth confirmed that the colony is not mixed with JCL260 ∆lysA alsS ∆galK).
Cells from randomly selected purple colonies were transformed with pSA65 and tested for
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isobutanol production performance.
Table 3.2: Additional strains employed in the studies described in Chapter 3
Strain Relevant genotype Reference
JCL260 ∆lysA alsS ∆galK JCL260 ∆lysA alsS ∆galK::cat This study
JCL260 ∆lysA yfp JCL260 ∆lysA::FRT ∆intC::yfp-cat This study
JCL260 ∆lysA alsS aceK-mut JCL260 ∆lysA alsS mutS- with AceK mutation
P510S
This study
K12 ∆ilvD pSAS31 K12 ∆ilvD ::FRT pSAS31 This study
K12 ∆ilvD cfp pSAS31 K12 ∆ilvD ::FRT ∆galK::cfp-bla pSAS31 This study
Table 3.3: Additional plasmids used in the studies described in Chapter 3
Plasmid Relevant genotype Reference
pSIM5 Red expression plasmid;
chloramphenicol-resistant
[84]
pET-ara-mCherry Arabinose-inducible mCherry
expression plasmid;
kanamycin-resistant
[108]
pSAS31 Constitutively expressed
mNeonGreen plasmid;
kanamycin-resistant
[107]
pBT1-proD-mCherry Constitutively expressed
mCherry plasmid;
ampicillin-resistant
Addgene plasmid #65823
70
Table 3.4: Primers and oligos employed in the studies described in Chapter 3
Name Sequence 5’ → 3’
mutS STOP JM G*C*G*G*AACTGCTGTATGCAGAAGATTTT
GCTGAAATGTCGTGATGATAAGGCCGTCG
CGGCCTGCGCCGTCGCCCGCTGTGGGAG
TTTGAA
mutS mut as for CAGAAGATTTTGCTGAAATGTCGTG
mutS mut as rev GGGTGATTTCCAGATTACGACG
mutS seq for GATATCAGTTCCGGGCGTTT
mutS seq rev GTTCTCGACGCCAAAACC
galK cat for GTTTGCGCGCAGTCAGCGATATCCATTTTC
GCGAATCCGGAGTGTAAGAACGTTGATCGG
CACGTAAG
galK cat rev CGGAAGAGCTGGTGCCTGCCGTACAGCAAG
CTGTCGCTGAACAATATGAATTACGCCCCGCC
CTGCCA
aceK 510 mut oligo G*G*C*G*CATAGCCAGTGGCGAAACTCTTCCG
GGAAAACATCGCCCGACGAGACGCTGTACCA
CGGTTCGCTGGCAAGTTCGTCTTCCGGATA
aceK mut as for CCGTGGTACAGCGTCTCGT
aceK mut as rev TCTGCCTTTGAGTTGGCTTT
aceK seq for CGCGTCTTATCATGCCTACA
aceK seq rev TCTGCCTTTGAGTTGGCTTT
* indicates phosphothoriated bond
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Chapter 4: Chromosomal integration and
optimization of isobutanol pathway in E. coli
4.1 Introduction
Chromosomal integration of recombinant genes is desirable compared to expression
from plasmids due to increased stability and elimination of the need for antibiotics for en-
suring plasmid maintenance. Antibiotics are costly, can lead to the spread of antibiotic
resistance, and also place additional stress on the cells. Chromosomal integration requires
optimization of expression level. Options for achieving optimal expression levels include
variation of the integrated gene’s copy number, genome position, promoter/ribosome bind-
ing site, or post-transcriptional elements.
One strategy for stable integration at adjustable copy numbers is Chemically Inducible
Chromosomal Evolution (CIChE), developed by Tyo et al. [59]. In this method, the genes to
be integrated, as well as a chloramphenicol resistance gene (cat) are flanked by matching 1
kb homology regions that are not homologous to the E. coli chromosome (in [59] they were
taken from Synechocystis PCC6803). Once this construct is integrated into the genome,
the strain is passaged into higher concentrations of chloramphenicol. Strains can use RecA-
mediated recombination to produce multiple copies of the integrated construct, giving them
a growth advantage in the high chloramphenicol concentrations. The recA gene is then be
deleted, stabilizing the strain. The method is summarized in Fig. 4.1. CIChE was first
demonstrated for producing the biopolymer poly-3-hydroxybutyrate, and it increased the
stability ten-fold compared to a strain with two plasmids carrying the pathway. It has also
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been utilized with triclosan as the selection agent [109].
Another possibility for modulating the expression level of an integrated gene is by
the choice of its integration location. Different chromosomal positions are known to have
different expression levels [107,110,111], but it is not well understood how culture condition
affects these levels. It is also not easy to predict how an integrated construct will affect
the expression at that site, and it can vary depending on what the construct is [62]. The
integrated construct itself can also have effects on the surrounding genes, which needs to be
considered. Thus, expression optimization by chromosomal position-dependent expression
variation is an underexplored strategy.
Figure 4.1: Overview of the CIChE method, applied for kivd and adhA. Passaging of cells into
successively higher concentrations of chloramphenicol (A) selects for cells that have performed
RecA-mediated recombination to increase the copy number of the genes of interest, which are
flanked by 1 kb homology regions (B). This figure is adapted from [59].
4.2 Results
4.2.1 Investigation of plasmid burden
To investigate the effect of plasmid burden on the isobutanol production strains, we
grew the NV3r1 strain with and without the isobutanol pathway genes in several different
media with and without inducer (IPTG). We observed that when the strains were under
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richer medium conditions, with yeast extract supplement, the growth rate was not affected
by plasmids or antibiotics. Under minimal medium conditions, however, the strain with
plasmids and antibiotics had severe growth defects. Therefore, integration of the pathway
is expected to provide a benefit in terms of growth rate, leading to an increased production
rate as well.
Figure 4.2: Growth profiles of NV3r1 with and without pSA65/9 plasmids, with and without IPTG
induction, in several different media.
4.2.2 Integration and copy number optimization of kivd/adhA genes
To integrate and optimize copy number of the kivd and adhA genes we used CIChE.
We integrated the PLlacO1-kivd-adhA operon into the aslB locus of NV3r1 by λ-Red re-
combination, as described in the Materials and methods section of Chapter 2. The aslB
site was chosen due to work showing that it is a highly expressed location [111]. We then
passaged the resulting integrant in LB medium with successively doubled concentrations of
chloramphenicol and then knocked out the recA gene by P1 transduction. The copy number
of resulting strains was assessed by qPCR (Fig. 4.3A). The strains were also transformed
with the pSA69 plasmid and tested for isobutanol production in monocultures in M9
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Figure 4.3: Characterization of integrated strains. (A) Construct copy number of strains after CI-
ChE and recA deletion. Error bars represent the propagated standard deviation of three technical
replicates of both cat gene PCR and bioA reference gene PCR. Isobutanol production after trans-
formation with pSA69 in (A) M9IPG medium with 5 g/L yeast extract (B) and TMM (C). Labels
indicate strain and which antibiotics were added to the culture. Percentages above the graphs rep-
resent the final percentage of the theoretical yield that was produced based on how much glucose
was consumed. Error bars represent the standard deviation of three biological replicates.
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medium with yeast extract (Fig. 4.3B) and in Trichoderma Minimal Medium (TMM), pH
6 (Fig. 4.3C). We found that the copy number increases with increasing copy number until
it plateaus around 60 copies. In the more optimal M9IPG medium, with yeast extract and
neutral pH, the strain with six copies performed similarly to the strain with 44 copies. In
minimal medium, however, the strain with 44 copies much better than the one with six
copies. This further highlights the usefulness of the strategy since the strains can be tuned
to find the optimal expression for a given process condition.
4.2.3 Construction and screening of alsS transposon integration library
To integrate the alsS gene, we decided to explore position-dependent expression varia-
tion by creating a library in which the gene is randomly integrated into various sites in the
genome (Fig. 4.4). We performed this integration using the transposon Tn5 to integrate
copies of the alsS gene as well as a kanamycin resistance gene to use for selection. We
integrated into JCL260 ∆lysA and produced a library of 3.4 ± 1.1 ∗ 104 members. When
library members were randomly selected, transformed with pSA65 and tested for isobutanol
production, only one (of 12) colony produced significant amounts of isobutanol (data not
shown). We therefore employed the SnoCAP screening strategy described in Chapters 2 & 3,
in the microdroplet format. We encapsulated the library as well as several controls secretor
strains along with the sensor strain K12 ∆ilvD ∆galK::cfp-amp pSAS31, and incubated to
allow co-growth. The fluorescence profile of the droplets showed that the library had a higher
percentage of fluorescent droplets compared to the parent strain (Fig 4.5A). We then sorted
the droplets for those with high fluorescence, pooled the collected droplets, and plated them
on plates with tetracycline to isolate secretor strain colonies. When colonies were rescreened
in the microplate format of SnoCAP, the growth profiles demonstrated that we had removed
the low performers (such as those visible in the randomly selected library members plot)
(Fig 4.5B).
We also tried integrating kan-PLlacO1-alsS-ilvCD into the genome using the same
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method as described above. This construct it larger (∼6.3 kb) and produced a smaller
library size (6.0 ± 2.7 ∗ 103 members). When screened by SnoCAP in droplets at various
concentrations of norvaline, no significant growth was observed. We hypothesize that this
apparent lack of productivity may be due to problems with the integration of such a large
construct by the transposon method (i.e., although the cells acquire the antibiotic resistance
they may not acquire all of the rest of the construct).
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Figure 4.4: Overall schematic of transposon library construction and screening. A transposome
containing alsS and the kanamycin-resistance gene is integrated into random genome positions in
the parent strain JCL260 ∆lysA. The resulting library is screened by SnoCAP screening in the
microdroplet format. Pools of sorted droplets are plated on LB plates with tetracycline to isolate
the secretor strains.
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Figure 4.5: Screening of alsS integration library. (A) Histogram comparing fluorescence signal from
droplets containing co-cultures with secretor strain JCL260 ∆lysA, JCL260 ∆lysA pSA69, and the
alsS transposon integration library. K12 ∆ilvD ∆galK::cfp-amp pSAS31 was used as sensor strain,
and the medium contained 1.0 g/L norvaline. ∼70,000 of each of the control droplets (JCL260
∆lysA, JCL260 ∆lysA pSA69) and ∼190,000 of the library droplets were analyzed. (B) Co-growth
profiles of library-isolates with and without screening, compared to controls, with sensor strain K12
∆ilvD, without norvaline.
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We transformed several of the fastest co-growing isolates (named d2, ds-1-4, ds-1-8,
ds-1-9, ds-1-11, ds-2-7, ds-2-8, ds-3-1, ds-3-8) with pSA65 and tested isobutanol production.
They displayed improved production compared to the parent strain (Fig. 4.6). Thus, the
screening successfully enriched for the higher producers. It is interesting to note that, while
in medium with yeast extract the isolates all have quite similar production levels, under
minimal medium there is more variation. The production levels are also generally higher
under the minimal medium conditions, likely due to higher expression of the ilvCD genes
since under these conditions the strain must produce branched chain amino acids for growth.
Figure 4.6: Isobutanol production of isolates from screening alsS integration library. Production
testing was carried out after transformation with plasmid pSA65, in M9IPG medium with (A) and
without (B) yeast extract.
4.3 Discussion and conclusion
This chapter has presented work on developing E. coli strains with the isobutanol
pathway integrated into the genome. We utilized CIChE to integrate the kivd and adhA
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genes at high copy numbers, generating strains with isobutanol production levels (with the
pSA69 plasmid) that are comparable to the double plasmid strain. One consideration in
using the CIChE method is that it requires the deletion of the recA gene to stabilize the
strain. Under certain contexts this deletion may be deleterious to the cells since recA is
important for DNA repair. If necessary, other methods of multiple copy integration, such as
the flippase-based method of Gu et al. [60], can be used to circumvent this problem.
We also constructed and screened a library with alsS inserted into random locations
in the genome. This alsS library has a relatively high percentage of strains that can grow
in the droplets in 1.0 g/L norvaline (∼1 in 25 in one set of droplets and ∼1 in 100 in an-
other set). While it is possible to find improved isobutanol-producing strains by randomly
selecting colonies from this library without screening, the majority are low-producers. The
screening successfully enriched for the higher producers. Future work can be done to multi-
plex integration of the ilvCD genes with the alsS integration. Because the alsS library has
a relatively high percentage of good producers compared to the model libraries we tested,
we expect the screening can be effective in screening this type of multiplexed library.
Future work should also be done to explore the mechanism by which the higher produc-
ers from the alsS integration library achieve their high-production phenotypes. Expression
level analysis and genomic position determination by transposon footprinting are expected
to provide information about the optimal expression level of this gene. It will also be inter-
esting to see whether alsS expression level varies under minimal compared to yeast extract-
supplemented conditions.
4.4 Materials and methods
4.4.1 Chemically Inducible Chromosomal Evolution (CIChE)
CIChE was performed in NV3r1 as described in Chapter 2. The CIChE construct was
then amplified from the pTGD-adhA-kivd plasmid using aslB integr for and aslB integr rev
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(see Table 2.3), which add 40 bp regions of homology to the aslB locus of the E. coli
genome. The construct was integrated into the NV3r1 genome using λ-Red recombineering
with pSIM6 [84] with selection on LB plates with 20 µg/mL chloramphenicol. A resulting
integrant (named NV3r1 cm 20) was verified by PCR and Sanger sequencing. Subsequently,
CIChE was performed by growing NV3r1 cm 20 to saturation and passaging into in suc-
cessively higher concentrations of chloramphenicol (cells were passed 1% v/v, and antibiotic
concentration was doubled in each passage). The recA gene was then deleted from cells
at various final levels of chloramphenicol by P1 transduction from donor strain BW 26,547
∆recA::kan Lambda recA+, which was obtained from the Coli Genetic Stock Center (CGSC).
Transductants were selected on LB plates with 50 µg/mL kanamycin and the corresponding
concentration of chloramphenicol.
4.4.2 qPCR for gene copy number determination
qPCR was performed with the same primers as [59], amplifying a portion of the cat gene
and also of bioA as a single copy reference gene. Reactions were performed in 25 µL samples
on an MJ Research (BioRad) Chromo4 thermocycler with SYBR Green qPCR Master Mix
(Life Technologies). A strain with a single copy of cat integrated (NV3r1* intC::yfp-cat,
from Chapter 4) was diluted and used to construct a standard curve.
4.4.3 Isobutanol production cultures
Isobutanol production cultures and metabolite measurements by HPLC was performed
as described in Chapter 2.
4.4.4 Transposon integration of kan-alsS
kan-PLlacO1-alsS was amplified by PCR from the pSA69 plasmid, adding the Tn5 mo-
saic ends. phosph transp kan for (5Phos/CTGTCTCTTATACACATCTACCGAGCGTTC
TGAACAAAT) and phosph transp alsS rev (5Phos/CTGTCTCTTATACACATCTGGTG
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ATTCCTCGTCGACCTA), where 5Phos/ represents a 5’ phosphorylated primer. The prod-
uct was then digested with both DpnI and SpeI enzymes (NEB) to digest the template
plasmid, phosphorylated with T4 polynucleotide kinase (NEB) in case of lost phosphory-
lation during the previous steps, cleaned with a PCR clean-up kit (Qiagen) and eluted in
TE buffer, and reacted with EZ-Tn5 transposase (Lucigen) according to the manufacturer’s
instructions. The resulting transposome was then electroporated into competent JCL260
∆lysA::FRT. The cells were recovered for 1 hr with 1 mL SOC medium. Then 50 µL was
used for dilution and plating on LB with kanamycin plates to assess library size, and the re-
maining ∼1050 µL of cells were grown to saturation in 100 mL LB with 50 µg/mL kanamycin
to select for successful integrants. The cells were then frozen in 1 mL aliquots (resuspended
in fresh LB with 25% glycerol) and later thawed, washed, and grown in LB with 50 µg/mL
kanamycin to prepare them for screening.
4.4.5 SnoCAP screening
SnoCAP screening, in droplet and microplate formats, was employed as described in
Chapters 3 and 2, respectively. Stationary phase cultures in LB were used as the inocula for
both formats. The droplet collection device was soaked in a mixture of HFE-7500 oil and
water for several days prior to use in order to improve droplet stability after collection.
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Chapter 5: Strategies for improving fungal-bacterial
co-culture for more efficient CBP
5.1 Introduction
Lignocellulosic biomass is an abundant and underutilized carbon source that does not
compete with food supply. It is therefore a promising feedstock for sustainable production of
liquid biofuels. The major challenge to cost-effective conversion of lignocellulosic biomass is
that it must be broken down into soluble sugars before it can be fermented. Use of synthetic
microbial consortia can help to address some of the limitations of monoculture bioprocessing,
including high metabolic burden on the cells and the need to optimize multiple pathways or
functions in the same species. Design of synthetic microbial consortia, however, brings the
challenge of identifying or engineering strains that can perform optimally within a mixed
population. Previous study has shown that a mixed culture of Trichoderma reesei and Es-
cherichia coli can co-exist stably and directly convert cellulosic biomass to isobutanol, a
promising biofuel candidate [53]. The production yield, titer, and rate require improvements
for the process to be economically viable on an industrial scale. The increase in byproduct
levels compared to monoculture fermentations and the instability of the plasmids encoding
the isobutanol production pathway indicate that our E. coli strains are suboptimal for func-
tion in the co-culture and the hydrolysis rate is a major limiting factor in the process. In this
chapter, we investigate approaches to improve co-culture performance. First, we knocked out
competing pathways in an effort to decrease byproduct production and increase isobutanol,
which did not prove successful. Second, we began work toward adaptive co-evolution of the
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T. reesei/E. coli co-culture.
5.2 Results
5.2.1 Deletion of competing pathways
We observe a significant difference in the distribution of products generated by E. coli
in co-culture with T. reesei compared to monoculture (Fig. 5.1). Additionally, we see
plasmid loss from the E. coli, with only ∼50% of viable cells retaining both plasmids after 8
days [53]. These behaviors indicate that there is room for optimization of the E. coli strains
to perform better under co-culture conditions. We also observe significant differences in
the product distributions on the two types of substrate examined (microcrystalline cellulose
(MCC) and AFEX-pretreated corn stover), indicating that the feedstock conditions greatly
affect E. coli metabolism.
Figure 5.1: Major fermentation products of T. reesei RUT-C30/E. coli NV3 pSA55/69 co-cultures
on AFEX pretreated corn stover (A) or microcrystalline cellulose (B), and of monocultures of E.
coli NV3 pSA55/69 on glucose (C, D). Adapted from [53].
We first investigated targeted gene deletion in NV3 with the goal of reducing losses
to side products and increasing isobutanol production. Knockouts of the adhE, pta, and
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frdB were implemented with the goal of reduction in ethanol, acetate, and succinate pro-
duction, respectively, These gene deletions were successful in reducing byproduct formation
and increasing isobutanol production in monoculture (Fig. 5.2A). On MCC, they led to a
reduction in ethanol and acetate and no significant change in succinate or isobutanol (data
not shown). The knockout strain did not show any significant improvement compared to
the base strain when co-cultured on AFEX-pretreated corn stover (Fig. 5.2B). Some of
the lack of improvement in co-culture performance may be to reduced growth performance
in the minimal, pH 6 medium used to grow the co-culture (Fig. 5.3). We also observed
significant variability in our co-culture experiments, both between biological replicates in
the same experiment and between experiments. This led us to pursue a directed evolution
approach to develop strains that are better adapted to the co-culture environment.
Figure 5.2: Major fermentation production of co-cultures with E. coli modified to knock out com-
peting pathways. (A) E. coli monoculture fermentation products after 95 h fermentation in 36 g/L
glucose M9 isobutanol production medium. Error bars represent standard deviation across two
replicates. (B) Major fermentation products of T. reesei/E. coli co-cultures after 384 h on 20 g/L
AFEX-pretreated corn stover. Error bars represent standard deviation across two replicates.
5.2.2 Toward adaptive evolution of T. reesei/E. coli co-cultures
We began our adaptive evolution strategy by growing mutagenized populations of E.
coli wildtype K12 population strains and growing them in media made from T. reesei/E.
coli co-culture supernatant supplemented with norvaline. This strategy was appealing since
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Figure 5.3: Growth properties of NV3 ∆adhE, NV3 ∆pta, NV3 ∆adhE ∆pta, ∆adhE ∆pta ∆frdB
on Trichoderma minimal medium with glucose, pH 6 (TMMG) (A) or M9 isobutanol production
medium (M9IPG) (B) with specified amounts of yeast extract in a 96-well microplate. Error bars
represent standard deviation of three biological replicate wells.
growth is faster on glucose, allowing more generations of selection in a given time span, and
because in monocultures E. coli growth can be screened using optical density. The resulting
strains that showed improved growth under these conditions showed improved growth relative
to K12 pSA65/69, which does not produce any isobutanol in co-culture with T. reesei, but
strains growing on 12 g/L norvaline in supernatant only produced up to several hundred
mg/L in co-culture, significantly less than the NV3(r1) strains.
We therefore undertook selection and screening in co-culture with T. reesei. Our T.
reesei did show inhibition by norvaline (Data not shown). To screen for E. coli growth
rate in co-culture, we have developed a fluorescence-based assay. The gene encoding yellow
fluorescent protein (YFP) under a constitutively expressed promoter was integrated by P1
transduction into the genome of an NV3r1 isolate from the end of a co-culture with high
isobutanol productivity (NV3r1*) and of wild-type K12. It is known that K12 has a higher
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Figure 5.4: Use of fluorescence for monitoring E. coli growth in T. reesei/E. coli co-culture. (A)
Fold increase in fluorescence (relative to a non-fluorescently labeled co-culture) and in viable E.
coli cells. Error bars represent propagated standard deviations from two biological replicates. (B)
Growth curve of E. coli K12 yfp and NV3r1* yfp in 24-well microplate measured by fluorescence
(two replicates of each), along with a non-fluorescent control. The three-hour gap represents a
period where the plate continued to be incubated and shaken, but the measurements were lost due
to instrument error.
growth rate in co-culture with T. reesei than NV3 strains [53]. We therefore tested to see if
by growing these strains in co-culture in a 24-well black microplate (600 µL per 3 mL well
volume) and measuring the fluorescence (excitation: 485 nm, emission: 528 nm) we could
observe the difference in growth rate. Flask cultures were conducted simultaneously and
samples were periodically serially diluted and plated on LB agar plates to verify the difference
in E. coli growth rates. Samples from the flask cultures were also read for fluorescence (in
96-well plates, so numbers are not directly comparable to the 24-well plate readings).
The data shown in Fig. 5.4A indicates that the culture’s fluorescence is a reasonable
quantitative indicator of E. coli count during the growth phase. The microplate growth
curves (Fig. 5.4B) also show a clear growth advantage during the early hours for K12 yfp in
comparison to NV3r1* yfp. Although microplate conditions clearly differ significantly from
those of a flask in terms of aeration and shaking (later during the cultivation the microplate
cultures begin to form clumps, disrupting fluorescence measurement), this experiment indi-
cates that the microplate growth curve correlates with the flask growth rate in the co-culture
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environment and that we can use relative microplate growth rates with norvaline to screen
for the best growing isolates.
We mutagenized NV3r1* using N-Methyl-N’-nitro-N-nitrosoguanidine (NTG), follow-
ing the procedure of [11]. We then inoculated co-cultures with approximately 7x108 E. coli
cells and T. reesei RUT-C30 for an approximate initial ratio of 0.1 gDW E. coli :1 gDW
RUT-C30. By taking samples and measuring the fluorescence in 96-well microplates, we
observe growth in the norvaline-supplemented cultures (Fig. 5.5A). After 210 hours, when
E. coli appeared to have reached stationary phase and fluorescence no longer increased, we
subcultured into fresh media. After 218 hr, the second subculture was serially diluted and
plated in on TMM 20 g/L MCC plates, TMM 20 g/L MCC plates with norvaline, and on
LB plates. E. coli colonies were observed on the MCC cellulose plates and were isolated for
transformation with the isobutanol pathway plasmids. However, upon testing in co-culture
for isobutanol production, they did not show improvement compared to the parent. We
hypothesize that using a strain with the isobutanol pathway integrated into the genome may
allow for a better outcome of the adaptive evolution since the co-culture can be immedi-
ately testing, instead of isolating the E. coli into monoculture for plasmid transformation,
which may be counter-selecting for the traits we desire for co-culture performance. It would
also allow for co-evolution of the two strains since the population can be collectively tested
without isolating monocultures.
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Figure 5.5: Fluorescence of co-cultures with mutagenized E. coli population. (A) Fluorescence
of NTG-mutagenized NV3r1* populations grown in co-culture with T. reesei on 0, 1, or 2 g/L
norvaline in 50 mL volume. Samples were read in a 96-well black microplate (200 µL per well).
(B) Fluorescence of subculture #1 flasks, inoculated 1% by volume from a NV3r1* yfp culture on
2 g/L norvaline at 210 hr.
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5.2.3 Investigation of β-glucosidase addition to co-cultures
On the hydrolysis side, we hypothesized that β-glucosidase might be a limiting factor
in performance since it is commonly found to be a bottleneck in hydrolysis [112]. To test
this, we added commercial β-glucosidase to co-cultures. While this addition led to a main-
tained increase in β-glucosidase activity over the culture period, it did not boost isobutanol
production (Fig. 5.6). Sugar liberation may not be the limiting factor affecting fermentation
performance.
Figure 5.6: T. reesei/E. coli NV3r1* co-cultures with and without β-glucosidase supplementation.
(A) β-glucosidase activity over time. (B) Isobutanol titers after 6 days of culturing. (A) and (B)
show data for the same set of cultures (three replicates of each condition).
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5.3 Discussion and conclusion
In this chapter, we have examined potential strategies for improving T. reesei/E. coli
co-culture isobutanol production performance. The strategy for eliminating competing path-
ways proved ineffective at increasing co-culture production levels. Under the low glucose,
low pH conditions of the co-culture, the E. coli cells are presumably in a very different state
than in high glucose, ideal monoculture conditions. Due to the complexity of the conditions,
we expect an evolutionary strategy may be a more effective approach. We demonstrated that
fluorescence could be used to monitor E. coli growth while it is co-cultured with RUT-C30.
We expect that this can be an effective strategy when employed with an E. coli strain that
contains a stably integrated isobutanol pathway. Utilizing SnoCAP to screen for strains that
produce well under co-culture conditions also appears to be a promising approach.
5.4 Materials and methods
5.4.1 Strains and plasmids
Strains and plasmids used in the work presented in this chapter are listed in Tables
5.1 and 5.2.
5.4.2 Gene deletions
Gene deletions were constructed by P1 phage transduction as previously described
in [82, 83] and in Chapter 2. Keio strains were used as the donor strains and LB agar with
50 µg/mL kanamycin was used as the selective medium. Transductants were purified from
residual P1 phage by isolation streaking on LB agar supplemented with 0.8 mM sodium
citrate and 50 µg/mL kanamycin. The FRT-flanked kanamycin resistance gene was using
the pCP20 plasmid to express FLP-recombinase.
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5.4.3 Co-cultures
Medium preparation and culture setup were performed as in [53]. Cultures were of
10 mL volume in 125 mL polypropylene baﬄed flasks. IPTG (an added concentration of
0.1 mM) was added to cultures every 3-5 days. Glucose and fermentation products were
assessed by HPLC, as described in Chapter 2. For the evolution experiments, co-cultures
were cultured in 600 µL volume in 24-well black, clear-bottom microplates in an SpectraMax
M5 plate reader (Molecular Devices) at 30 oC, with shaking, on TMM, buffered with 0.1 M
maleate-NaOH, pH 6, 20 g/L MCC.
5.4.4 E. coli monoculture growth characterization
Cells were grown overnight in LB, washed twice with PBS, resuspended to an optical
density corresponding to ∼109 CFU/mL, and inoculated 1:100 into the specified medium.
Cultures were vortexed and then distributed into a 96-well clear microplate (Brand), 200 µL
per well. The microplate lid was coated with a solution of 0.5% Triton X-100 in 20% ethanol
to reduce condensation and lids were fastened with tape. The microplate was incubated
at 30 oC, with shaking in a VersaMax plate reader (Molecular Devices), with absorbance
readings at 600 nm taken every 10 min. µmax was calculated via linear regression of natural
log of OD600 values (after subtracting blank values) vs. time.
5.4.5 β-glucosidase activity
β-glucosidase activity was measured by reaction on 4-nitrophenyl β-D-glucopyranoside
(pNPG) to produce a colored product, as previously described [113]. In a 96-well microplate,
25 µL of appropriately diluted sample was mixed with 25 µL ultrapure water and µL 200
mM pH 4.8 citrate buffer and incubated at 50 oC for 5 minutes. 25 µL 10 mM pNPG was
then added and the plate was incubated 10 min at 50 oC. 100 µL of NaOH-glycine buffer
(0.4 M, pH 10.8) was added to stop the reactions and absorbance was measured at 405 nm.
One IU is defined as the amount of enzyme required to release 1 µmole of pNP per minute
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(extinction coefficient = 18,000 1/(M*cm).
Table 5.1: Strains employed in the studies described in Chapter 5
Strain Notes Reference
NV3 Norvaline resistant mutant strain [11]
NV3r1 NV3 with rpoS mutation
repaired
[11]
NV3r1 ∆adhE ∆pta ∆frdB NV3r1 ∆adhE ::FRT ∆pta::FRT
∆frdB ::FRT
This study
NV3r1* Possibly mutated version of
NV3r1, isolated from a T.
reesei/E. coli co-culture
This study
NV3r1* yfp NV3r1* ∆intC::yfp-cat This study
K12 yfp K12 ∆intC::yfp-cat This study
RUT-C30 Trichoderma reesei strain
engineered for hypersecretion of
cellulases
ATCC 56765; [55]
Table 5.2: Plasmids used in the studies described in Chapter 5
Plasmid Relevant genotype Reference
pSA55 ColE1 ori; AmpR;
PLlacO1::kivd–ADH2
[10]
pSA65 ColE1 ori; AmpR;
PLlacO1::kivd–adhA
[81]
pSA69 p15A ori; KanR;
PLlacO1::alsS–ilvC–ilvD
[81]
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Chapter 6: Concluding remarks and future
directions
6.1 Summary
This dissertation has demonstrated the use of microbial cross-feeding systems as a
tool for high-throughput screening of strain libraries, as well as explored strategies for opti-
mizing strains for co-culture-enabled consolidated processing of lignocellulosic biomass. In
the first part of the work, we have developed a screening framework based on cross-feeding
auxotrophs, Syntrophic Co-culture Amplification of Production phenotype (SnoCAP). This
framework has unique features that are not possible in a monoculture system. The cross-
feeding configuration maintains the target molecule as limiting, thus producing a wider
and more tunable dynamic range than that of a monocultured auxotrophic biosensor. Ad-
ditionally, the exponential growth of the culture amplifies small differences in production
level between strains into much more significant differences in growth phenotype of the co-
cultures. We demonstrate three formats of compartmentalizing individual secretor genotypes
with sensor strain: confinement in wells of microtiter plates, spatial separation as colonies on
agar plates, and encapsulation in water-in-oil microdroplets. We also demonstrated that the
dynamic range of the assay may be tuned by the addition of an inhibitory analog and that,
by a push-pull strategy, SnoCAP can be extended to screening for secondary metabolites
that are several steps removed from a primary metabolite. As demonstrations of SnoCAP’s
utility, we screened model libraries consisting of mixtures of two production level strains.
We also employed the agar plate format of SnoCAP to screen a chemically mutagenized li-
95
brary and identified an efficient isobutanol producing strain. This strain nearly matches the
production levels of the double plasmid strain, but it carries only one plasmid. The pyruvate
to isobutanol conversion in this strain is accomplished by genomic mutations rather than by
overexpression of the pathway genes.
In the second part of this work, we considered strategies for improving a synthetic
fungal-bacterial co-culture for consolidated bioprocessing of lignocellulosic biomass into the
biofuel isobutanol. One approach we took was integration of the isobutanol pathway genes
into the bacterial genome, which is desirable for stability and cost-reduction. We first
integrated the two genes responsible for the conversion of 2-ketoisovalerate (2-KIV) into
isobutanol and increased their copy number by chemically inducible chromosomal evolution
(CIChE), achieving similar production levels to the strain containing these genes on a plas-
mid. We next developed a method of optimizing expression level by random integration
into genome positions with varying expression levels followed by SnoCAP screening. From
a library of alsS integrants, we identified strains with significantly higher production levels
than the parent strain, although not as high as the strain with the plasmid. This is to be
expected since the plasmid overexpresses three genes that convert pyruvate to 2-KIV and we
only integrated one of them. We also developed a strategy for adaptive laboratory evolution
of the fungal-bacterial co-culture that we expect can be useful toward developing a more
robust and productive process.
6.2 Future directions
6.2.1 Future directions for the SnoCAP platform
There is increasing interest in production of many chemicals from renewable resources
and the number of compounds that are commercially produced using microorganisms is on
the rise. As discussed in Chapter 2 Discussion and conclusion, we expect SnoCAP can be
readily applied to a variety of target compounds, including many for which other types of
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biosensors do not currently exist. Lee et al. [114] have recently compiled a comprehensive
bio-based chemicals map of compounds that can be produced by biological methods or
a combination of biological and non-environmentally harmful chemical methods from the
sugars present in lignocellulosic biomass. They also include a list of those that are being
produced on commercial scale and the best reported titers. Many of the compounds in
this map have not yet been explored as metabolic engineering targets and future work on
producing them can potentially benefit from SnoCAP screening.
We expect that constructing an auxotrophic sensor strain and identifying an appro-
priate partner auxotrophy will in some cases require far less work than development of a
protein- or nucleic acid-based sensor and also offers the benefits of signal amplification and
a tunable dynamic range. To speed the development of a new syntrophic pair-base screen, it
may be useful to apply predictive modeling for identifying appropriate complementary aux-
otrophies. Wintermute & Silver took a flux-balance analysis (FBA) modeling approach to
find shadow prices representing the benefit to a strain from consuming its required nutrient,
bA, and the cost, pB in terms of lost growth rate from secreting metabolite A. They defined a
cross-feeding strain’s cooperation efficiency as B = b
A/pB and found that this was predictive
of the co-culture behavior (Fig. 6.1). This approach can potentially be useful in choosing
an appropriate secondary cross-fed molecule for a given target production molecule. The
best initial level of cross-feeding with which to begin a SnoCAP screening will likely depend
on the target molecule and how much improvement is sought. For example, if a large degree
of improvement is expected then it will be beneficial to begin with a strain that has a low
level of initial co-growth with the parent strain.
A key challenge of metabolic engineering is the lack of predictive power. To better
inform computational models, we need to collect more data. High-throughput screening
methods, such as SnoCAP, combined with high-throughput sequencing to characterize library
members of different production levels can potentially help to reveal underlying principles
that can guide future metabolic engineering efforts.
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Figure 6.1: Prediction of co-growth properties based on flux-balance analysis (FBA) modeling.
Cooperation efficiencies,  were derived from a FBA model and are a measure of how well the strain
can cheaply produce metabolites that promote high-growth of the partner auxotroph. Reproduced
from [34].
SnoCAP for screening for E. coli productivity in co-culture with T. reesei A
future direction of SnoCAP relevant to the work presented in this dissertation could be
its application toward screening E. coli libraries for improved production when co-cultured
with Trichoderma on a cellulosic carbon source. The Trichoderma would liberate glucose
which would be consumed by itself, as well as by both E. coli strains (Fig. 6.2A). The co-
growth should be determined by the productivity of the secretor strain, allowing screening
for strains that are productive under the stresses of co-culture conditions (including limited
glucose, suboptimal pH).
To test the feasibility of this, we cultured RUT-C30 spores with the sensor strain and
either the high- or low-producing strain from Chapter 2 in tricultures in 200 µL volumes
in 96-well microplates in TMM medium with 20 g/L cellobiose. The plate was incubated
at 30 oC, with shaking, in a plate reader, reading optical density and green fluorescence at
intervals. We observed that the high-producing E. coli strain led to increased total optical
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density and fluorescence, as predicted (Fig. 6.2B). A control with only the sensor E. coli (no
secretor strain) showed an eventual increase in fluorescence, indicating that it can get some
of its needed metabolites from the Trichoderma. The low-producing secretor with sensor
produced similar profiles with the sensor only.
We next tested for co-growth in droplets by encapsulating the cells such that all droplets
contain Trichoderma spores and sensor E. coli cells and ∼10% contain a secretor cell. The
cells are again in TMM medium with cellobiose. In this case, the Trichoderma spores
germinated rapidly (with 12 hrs), but the E. coli did not show noticeable growth after 50 h.
By this time the Trichoderma have grown outside of the droplets (Fig. 6.2C). It may be
that this strain has too low of a production level under these settings to promote growth.
6.2.2 Future directions for T. reesei/E. coli co-culture development
It is clear from natural communities that microbial consortia are capable of perform-
ing complex tasks efficiently and robustly. Accumulation of a value-added product requires
engineering a synthetic consortium. Despite significant research efforts to develop design
principles for synthetic consortia, there are still relatively few examples of industrially imple-
mented consortia, which highlights the need for further development of tools for engineering
stable, productive co-cultures. In this dissertation we have begun investigation of isobutanol
pathway integration and optimization, which we predict can lead to a more stable co-culture
that can be subjected to further optimization by adaptive laboratory evolution.
Future work could be done on this project to integrate the ilvCD genes, combine this
library with the alsS library, and screen by SnoCAP to identify even higher 2-KIV/isobutanol
producers. Assessing the expression level and genomic location of these integrants should
shed light on optimal expression levels of these genes and may provide useful knowledge
for future pathway integration efforts. Screening can also be performed under different
conditions (e.g., low pH conditions which are more optimal for the T. reesei). Ultimately,
the best 2-KIV producers can then be combined with the CIChE integration of kivd/adhA
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Figure 6.2: Preliminary investigation of SnoCAP for screening E. coli for productivity under co-
culture with T. reesei. (A) Schematic of expected SnoCAP implementation with Trichoderma. (B)
OD600 and fluorescence profiles of tricultures and a biculture with only the sensor E. coli. The
replicates of each culture are shown, plotted in the same color. Due to setup error, the plate sat
for ∼7 hr at room temperature before beginning the kinetic run in the plate reader. Therefore by
the time indicated as 0 h there has likely already been some growth. Legend indicates the E. coli
strains present in the culture; all cultures also contain RUT-C30. (C) Tricultures before and after
50 h incubation in droplets.
to produce fully integrated strains. We expect these strains will be good starting points
for adaptive evolution efforts for isobutanol production when co-cultured with Trichoderma
reesei.
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